Document:

EXECUTION
VERSION

 

PLACEMENT
AGENCY AGREEMENT

 

December
1, 2016

 

Aegis
Capital Corp.

810
Seventh Ave, 18th Floor

New
York, NY 10019

 

Re:
Motus GI Medical Technologies Ltd. and Motus GI Holdings, Inc. 

 

Ladies
and Gentlemen:

 

This
Placement Agency Agreement (“Agreement”) sets forth the terms upon which Aegis Capital Corp., a New York corporation
(“Aegis” or “Placement Agent”), a registered broker-dealer and member of the Financial Industry
Regulatory Authority (“FINRA”), shall be engaged by Motus GI Medical Technologies Ltd., an Israeli corporation
(“OPCO”), and Motus GI Holdings, Inc., a Delaware corporation (“Issuer”), to act as exclusive
Placement Agent in connection with the private placement (the “Offering”) of units (“Units”)
of securities of Issuer, with each Unit consisting of (i) three-quarter (3/4) of a share of common stock, par value $0.0001 per
share (the “Common Stock”), of Issuer (the “Shares”) and (ii) one-quarter (1/4) of a share
of Series A Convertible Preferred Stock, par value $0.0001 per share (the “Preferred Shares”). Each holder
of Preferred Shares shall be entitled to “Royalty Payment Rights” as defined in the Certificate of Designations
of the Issuer.

 

The
Offering will consist of a minimum of 4,000,000 Units ($20,000,000) (the “Minimum Amount”) and a maximum of
5,000,000 Units ($25,000,000) (the “Maximum Amount”). As part of the Offering, holders of OPCO’s outstanding
convertible notes (the “Convertible Notes”) in the aggregate principal amount of $13,746,017, together with
accrued and unpaid interest thereon at the rate of ten percent (10%) per annum, accrued through the date of the First Closing,
will be exchanging principal and accrued interest thereon for a quantity of Units equal to the principal amount of their Convertible
Notes, plus accrued interest through the First Closing, divided by the Unit price of $4.50. Such exchange of Convertible Notes
into Units shall be included in the calculations of whether the Minimum Amount, Maximum Amount or Over-allotment of the Offering
has been reached. In addition, holders of certain warrants to purchase shares of OPCO common stock that were issued in connection
with the Convertible Notes will be exchanging such warrants for 5-year warrants to purchase shares of Issuer’s Common Stock
at an exercise price of $5.00 per share (the “Exchange Warrants”) in a quantity equal to thirty-three percent
(33%) of the principal amount of such Convertible Notes divided by $5.00.

 

In
the event the Offering is oversubscribed, Issuer and the Placement Agent may, in their mutual discretion, have Issuer sell up
to 1,000,000 additional Units for an additional aggregate purchase price of $5,000,000 (the “Over-allotment”).

 

    	 	 	 

    	 	 	 

    

 

Concurrently
with the initial closing of the Offering (the “First Closing”), Issuer will issue shares of its Common Stock
(currently estimated to be 4,000,000 in total) to OPCO’s then-existing stockholders and Issuer will issue options to purchase
shares of its Common Stock (currently estimated to be 125,731 in total) to OPCO’s then-existing holders of options to purchase
shares of OPCO’s common stock (the “Share Exchange”), pursuant to the terms of that certain Share Exchange
Agreement dated on or about the date hereof by and among OPCO, Issuer, the Stockholders of OPCO and Orchestra Medical Ventures
II, L.P. as Stockholder Representative (the “Share Exchange Agreement”). Pursuant to the Share Exchange Agreement,
all then-existing OPCO warrants (other than the warrants to be exchanged for Exchange Warrants) will be exercised by the holders
of such warrants, or if not exercised, be deemed automatically exercised, for shares of OPCO’s common stock, which shall
be exchanged for Issuer’s Common Stock. As a result thereof, OPCO will become a wholly-owned subsidiary of Issuer and continue
as an Israeli corporation, and will continue its existing operations. As used in this Agreement, unless the context otherwise
requires, the term “Company” refers to Issuer and OPCO on a combined basis after giving effect to the Offering
and the Share Exchange.

 

The
purchase price for the Units will be $5.00 per Unit (the “Offering Price”), with a minimum investment of $250,000;
provided, however, that subscriptions for lesser amounts may be accepted in the Issuer’s, OPCO’s and
Placement Agent’s joint discretion; provided, however, that in no event shall the Issuer be required to issue any fractional
Shares or Preferred Shares and any fractional Shares or Preferred Shares shall be rounded up to the nearest whole share The Placement
Agent shall accept subscriptions only from persons or entities who qualify as “accredited investors,” as such term
is defined in Rule 501 of Regulation D (“Regulation D”) as promulgated by the United States Securities and
Exchange Commission (the “SEC”) under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”).
The Units will be offered until the earlier of (i) the termination of the Offering as provided herein, (ii) the time that all
Units offered in the Offering are sold or (iii) March 1, 2016 (“Initial Offering Period”), which date may be
extended by Aegis on behalf of the Placement Agent and OPCO in their joint discretion until May 1, 2017 (this additional period
and the Initial Offering Period shall be referred to as the “Offering Period”). The date on which the Offering
expires or is terminated shall be referred to as the “Termination Date.”

 

With
respect to the Offering, OPCO and Issuer shall provide the Placement Agent, on terms set forth herein, the right to offer and
sell all of the Units being offered. Purchases of Units may be made by the Placement Agent and its officers, directors, employees
and affiliates. All such purchases, together with purchases by officers, directors, employees and affiliates of OPCO or Issuer,
may be used to satisfy the Minimum Amount. It is understood that no sale shall be regarded as effective unless and until accepted
by the Issuer and OPCO. The Issuer and OPCO may, in their joint discretion, accept or reject, in whole or in part, any prospective
investment in the Units. The Issuer, OPCO and the Placement Agent shall mutually agree with respect to allotting any prospective
subscriber less than the number of Units that such subscriber desires to purchase.

 

The
Offering will be made by Issuer solely pursuant to the Memorandum (as defined below), which at all times will be in form and substance
reasonably acceptable to Issuer, OPCO, the Placement Agent and their respective counsel and contain such legends and other information
as Issuer, OPCO, the Placement Agent and their respective counsel, may, from time to time, deem necessary and desirable to be
set forth therein. “Memorandum” as used in this Agreement means Issuer’s Confidential Private Placement
Memorandum dated on or about December 1, 2016, inclusive of all annexes, and all amendments, supplements and appendices thereto.

 

    	 	-2-	 

    	 	 	 

    

 

1.
Appointment of Placement Agent. On the basis of the representations and warranties provided herein, and subject to the
terms and conditions set forth herein, the Placement Agent is appointed as exclusive Placement Agent for OPCO and Issuer during
the Offering Period to assist OPCO and Issuer in finding qualified subscribers for the Offering. The Placement Agent may sell
Units through other broker-dealers who are Financial Industry Regulatory Authority (“FINRA”) members and may
reallow all or a portion of the Agent Compensation (as defined in Section 3(b) below) it receives to such other broker-dealers.
On the basis of such representations and warranties and subject to such terms and conditions, the Placement Agent hereby accepts
such appointment and agrees to perform its services hereunder diligently and in good faith and in a professional and businesslike
manner and to use its reasonable efforts to assist OPCO and Issuer in (A) finding subscribers of Units who qualify as “accredited
investors,” as such term is defined in Rule 501 of Regulation D, and (B) completing the Offering. The Placement Agent has
no obligation to purchase any of the Units. Unless sooner terminated in accordance with this Agreement, the engagement of the
Placement Agent hereunder shall continue until the later of the Termination Date or the Final Closing (as defined below).

 

2.
Representations, Warranties and Covenants of OPCO. Except as set forth on Schedule A hereto, or in the Memorandum, the
representations and warranties of OPCO (as used in this Section 2, “OPCO” refers to Motus GI Medical Technologies,
Ltd. and its subsidiaries, if any) contained in this Section 2 are true and correct as of the date of this Agreement

 

(a)
The Memorandum has been prepared by OPCO in compliance in all material respects with Regulation D and Section 4(a)(2) of the Act
and the requirements of all other rules and regulations (together, the “Regulations”) relating to offerings
of the type contemplated by the Offering, and the applicable securities laws and the rules and regulations of those jurisdictions
wherein the Placement Agent notifies OPCO that the Units are to be offered and sold.. The Units will be offered and sold pursuant
to the registration exemptions provided by Regulation D and Section 4(a)(2) of the Act as a transaction not involving a public
offering and the requirements of any other applicable state securities laws and the respective rules and regulations thereunder
in those United States jurisdictions in which the Placement Agent notifies OPCO that the Units are being offered for sale. None
of OPCO, its affiliates, or any person acting on its or their behalf (other than the Placement Agent, its affiliates or any person
acting on its behalf, in respect of which no representation is made) has taken nor will it take any action that conflicts with
the conditions and requirements of, or that would make unavailable with respect to the Offering, the exemption(s) from registration
available pursuant to Rule 506(b) of Regulation D or Section 4(a)(2) of the Act, or knows of any reason why any such exemption
would be otherwise unavailable to it. None of OPCO, its predecessors or affiliates has been subject to any order, judgment or
decree of any court of competent jurisdiction temporarily, preliminarily or permanently enjoining such person for failing to comply
with Section 503 of Regulation D. Except as set forth in the Memorandum, OPCO has not, for a period of six months prior to the
commencement of the offering of Units, sold, offered for sale or solicited any offer to buy any of its securities in a manner
that would be integrated with the offer and sale of the Units pursuant to this Agreement and would cause the exemption from registration
set forth in Rule 506(b) of Regulation D to become unavailable with respect to the offer and sale of the Units pursuant to this
Agreement in the United States. 

 

    	 	-3-	 

    	 	 	 

    

 

(b)
As to OPCO only, the Memorandum does not include any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not
misleading; provided, however, the foregoing does not apply to any statements or omissions made solely in reliance
on and in conformity with written information furnished to OPCO by Issuer or the Placement Agent specifically for use in the preparation
thereof. To the knowledge of OPCO, none of the statements, documents, certificates or other items made, prepared or supplied by
OPCO with respect to the transactions contemplated hereby contains an untrue statement of a material fact or omits to state a
material fact necessary to make the statements contained therein not misleading in light of the circumstances in which they were
made. There is no fact which OPCO has not disclosed in the Memorandum and of which OPCO is aware that materially adversely affects
or that could reasonably be expected to have a material adverse effect on the (i) assets, liabilities, results of operations,
condition (financial or otherwise), business of OPCO or (ii) the ability of OPCO to perform its obligations under this Agreement.
To the knowledge of OPCO, there are no facts, circumstances or conditions that could reasonably be expected to have an OPCO Material
Adverse Effect (as hereinafter defined) that have not been fully disclosed in the Memorandum. Notwithstanding anything to the
contrary herein, OPCO makes no representation or warranty with respect to any estimates, projections and other forecasts and plans
(including the reasonableness of the assumptions underlying such estimates, projections and other forecasts and plans) that may
have been delivered to the Placement Agent or its representatives or that are contained in the Memorandum, except that such estimates,
projections and other forecasts and plans have been prepared in good faith on the basis of assumptions stated therein, which assumptions
were believed to be reasonable at the time of such preparation.

 

(c)
OPCO is duly organized and validly existing in good standing under the laws of the jurisdiction in which it was formed, and has
the requisite power and authority to own its properties and to carry on its business as now being conducted. Except for Motus
GI, Inc., a Delaware corporation and wholly owned subsidiary of OPCO, OPCO is not a participant in any joint venture, partnership
or similar arrangement and does not directly or indirectly own any subsidiaries or otherwise own or hold capital stock or an equity
or similar interest in any entity. OPCO is duly qualified as a foreign entity to do business and is in good standing in every
jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification necessary,
except to the extent that the failure to be so qualified or be in good standing would not have a OPCO Material Adverse Effect.
As used in this Agreement, “OPCO Material Adverse Effect” means any material adverse effect on the business,
properties, assets, operations, results of operations or condition (financial or otherwise) of OPCO, taken as a whole, or on the
transactions contemplated hereby and the other OPCO Transaction Documents (as defined below) or by the agreements and instruments
to be entered into in connection herewith or therewith, or on the authority or ability of OPCO to perform its obligations under
the OPCO Transaction Documents (as defined below).

 

    	 	-4-	 

    	 	 	 

    

 

(d)
OPCO has all requisite corporate power and authority to conduct its business as presently conducted and as proposed to be conducted
(as described in the Memorandum), to enter into and perform its obligations under this Agreement, the Subscription Agreement substantially
in the form of Annex A to the Memorandum (the “Subscription Agreement”), the Registration Rights Agreement
substantially in the form of Annex B to the Memorandum (the “Registration Rights Agreement”), the Share Exchange
Agreement, the Escrow Agreement (as hereinafter defined) and the other agreements contemplated hereby (this Agreement, the Subscription
Agreement, the Registration Rights Agreement, the Share Exchange Agreement ,the Escrow Agreement (as hereinafter defined) and
the other agreements contemplated hereby that OPCO is executing and delivering hereunder are collectively referred to herein as
the “OPCO Transaction Documents”). Prior to the First Closing, each of the OPCO Transaction Documents (other
than this Agreement, which has already been authorized) will have been duly authorized. This Agreement has been duly authorized,
executed and delivered and constitutes, and each of the other OPCO Transaction Documents, upon due execution and delivery, will
constitute, valid and binding obligations of OPCO, enforceable against OPCO in accordance with their respective terms (i) except
as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws now or
hereafter in effect related to laws affecting creditors’ rights generally, including the effect of statutory and other laws
regarding fraudulent conveyances and preferential transfers, and except that no representation is made herein regarding the enforceability
of OPCO’s obligations to provide indemnification and contribution remedies under the securities laws and (ii) subject to
the limitations imposed by general equitable principles (regardless of whether such enforceability is considered in a proceeding
at law or in equity).

 

(e)
None of the execution and delivery of or performance by OPCO under this Agreement or any of the other OPCO Transaction Documents
or the consummation of the transactions herein or therein contemplated conflicts with or violates, or will result in the creation
or imposition of, any lien, charge or other encumbrance upon any of the assets of OPCO under any agreement or other instrument
to which OPCO is a party or by which OPCO or its assets may be bound, or any term of the certificate of incorporation or by-laws
of OPCO, or any license, permit, judgment, decree, order, statute, rule or regulation applicable to OPCO or any of its assets,
except in the case of a conflict, violation, lien, charge or other encumbrance (except with respect to OPCO’s certificate
of incorporation or by-laws) which would not reasonably be expected to have a OPCO Material Adverse Effect.

 

(f)
[Reserved]

 

(g)
OPCO’s financial statements, together with the related notes, if any, included in the Memorandum, present fairly, in all
material respects, the financial condition of OPCO as of the dates specified and the results of operations for the periods covered
thereby. Such financial statements and related notes were prepared to conform with United States generally accepted accounting
principles (“GAAP”) applied on a consistent basis throughout the periods indicated, and were audited in accordance
with Israeli audit standards. Except as set forth in such financial statements or otherwise disclosed in the Memorandum, OPCO
has no known material liabilities of any kind, whether accrued, absolute or contingent, or otherwise, and subsequent to the date
of the Memorandum and prior to the date of the First Closing it shall not enter into any material transactions or commitments
without promptly thereafter notifying the Placement Agent in writing of any such material transaction or commitment. The other
financial and statistical information with respect to OPCO and any pro forma information and related notes included in the Memorandum
present fairly in all material respects the information shown therein on a basis consistent with the financial statements of OPCO
included in the Memorandum.

 

    	 	-5-	 

    	 	 	 

    

 

(h)
Since the date of OPCO’s most recent financial statements contained in the Memorandum, there has been no OPCO Material Adverse
Effect. Except as disclosed in the Memorandum, since the date of OPCO’s most recent financial statements contained in the
Memorandum, OPCO has not (i) declared or paid any dividends, (ii) sold any assets, individually or in the aggregate, in excess
of $75,000 outside of the ordinary course of business or (iii) had capital expenditures, individually or in the aggregate, in
excess of $75,000. OPCO has not taken any steps to seek protection pursuant to any bankruptcy law nor does OPCO have any actual
knowledge or reason to believe that its creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge
of any fact which would reasonably lead a creditor to do so.

 

(i)
Except as described in the Memorandum, and except for intercompany indebtedness between Issuer and OPCO with respect to the Convertible
Notes, OPCO has no outstanding Indebtedness (as defined below) in excess of $50,000 and is not in violation of any term of or
in default under any contract, agreement or instrument relating to any Indebtedness, except where such violations or defaults
would not result, individually or in the aggregate, in an OPCO Material Adverse Effect. For purposes of this Agreement: (i) “Indebtedness”
of any Person (as defined below) means without duplication, (A) all indebtedness for borrowed money, (B) all obligations issued,
undertaken or assumed as the deferred purchase price of property or services including (without limitation) “Capital Leases”
(as defined under GAAP) (other than trade payables entered into in the ordinary course of business), (C) all reimbursement or
payment obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced
by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition
of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or other title retention
agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds of such
indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default are limited
to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which, in connection
with GAAP, consistently applied for the periods covered thereby, is classified as a Capital Lease, (G) all indebtedness referred
to in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent
or otherwise, to be secured by) any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property
or assets (including accounts and contract rights) owned by any Person, even though the Person which owns such assets or property
has not assumed or become liable for the payment of such indebtedness, and (H) except for obligations owed to service providers
of OPCO in connection with this Offering, all Contingent Obligations (as defined below) in respect of indebtedness or obligations
of others of the kinds referred to in clauses (A) through (G) above of at least $50,000; (y) “Contingent Obligation”
means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to any indebtedness,
lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability,
or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged,
or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole
or in part) against loss with respect thereto; and (z) “Person” means an individual, a limited liability company,
a partnership, a joint venture, a corporation, a trust, an unincorporated organization and a government or any department or agency
thereof.

 

    	 	-6-	 

    	 	 	 

    

 

(j)
The conduct of business by OPCO as presently and proposed to be conducted is not subject to continuing oversight, supervision,
regulation or examination by any governmental official or body of the United States, or any other jurisdiction wherein OPCO currently
conducts such business, except as described in the Memorandum. .

 

(k)
OPCO has obtained
all material licenses, permits and other governmental authorizations necessary to conduct its business as presently conducted.
OPCO has not received any written notice of any violation of, or noncompliance with, any federal, state, local or foreign laws,
ordinances, regulations and orders (including, without limitation, those relating to environmental protection, occupational safety
and health, securities laws, equal employment opportunity, consumer protection, credit reporting, “truth-in-lending”,
and warranties and trade practices) applicable to its business, the violation of, or noncompliance with, would have an OPCO Material
Adverse Effect (as defined below), and OPCO knows of no facts or set of circumstances which could give rise to such a notice.

 

(l)
No default by OPCO or, to the knowledge of OPCO, any other party, exists in the due performance under any material agreement to
which OPCO is a party or to which any of its assets is subject (collectively, the “OPCO Agreements”). The OPCO
Agreements disclosed in the Memorandum are the only material agreements to which OPCO is bound or by which its assets are subject,
are accurately described in the Memorandum and are in full force and effect in accordance with their respective terms, subject
to any applicable bankruptcy, insolvency or other laws affecting the rights of creditors generally and to general equitable principles
and the availability of specific performance.

 

(m)
Except as described in the Memorandum, OPCO owns
all right, title and interest in, or possesses enforceable rights to use, all patents, patent applications, trademarks, service
marks, copyrights, rights, licenses, franchises, trade secrets, confidential information, processes and formulations necessary
for the conduct of its business as now conducted (collectively, the “Intangibles”). To the knowledge of OPCO,
OPCO has not infringed upon the rights of others with respect to the Intangibles and, except as disclosed in the Memorandum, OPCO
has not received notice that it has or may have infringed or is infringing upon the rights of others with respect to the Intangibles,
or any written notice of conflict with the asserted rights of others with respect to the Intangibles. To the knowledge of OPCO,
all such Intangibles are enforceable and no others have infringed upon the rights of OPCO with respect to the Intangibles. None
of OPCO’s Intangibles have expired or terminated, or are expected to expire or terminate, within three years from the date
of this Agreement. All current officers, employees, consultants and independent contractors of OPCO
having access to proprietary information of Company, its customers or business partners and inventions owned by Company have executed
and delivered to Company an agreement regarding the protection of such proprietary information. OPCO has secured, by valid written
assignments from all of Company’s current and former consultants, independent contractors and employees who were involved
in, or who contributed to, the creation or development of any Intangibles, unencumbered and unrestricted exclusive ownership of
each such third party’s Intangibles in their respective contributions. To knowledge of OPCO, no current or former employee,
officer, director, consultant or independent contractor of Company has any right, license, claim or interest whatsoever in or
with respect to any Intangibles.

 

    	 	-7-	 

    	 	 	 

    

 

(n)
OPCO is not a party to any collective bargaining agreement nor does it employ any member of a union. No executive officer of OPCO
(as defined in Rule 501(f) of the Act) has notified OPCO that such officer intends to leave OPCO or otherwise terminate such officer’s
employment with OPCO. No executive officer of OPCO, to the knowledge of OPCO, is in violation of any material term of any employment
contract, confidentiality, disclosure or proprietary information agreement, non-competition agreement, or any other contract or
agreement or any restrictive covenant, and the continued employment of each such executive officer does not subject OPCO to any
liability with respect to any of the foregoing matters. OPCO is in compliance with all federal, state, local and foreign laws
and regulations respecting labor, employment and employment practices and benefits, terms and conditions of employment and wages
and hours, except where failure to be in compliance would not, either individually or in the aggregate, reasonably be expected
to result in an OPCO Material Adverse Effect.

 

(o)
As to OPCO only, no consent, authorization or filing of or with any court or governmental authority is required in connection
with the consummation of the transactions contemplated herein, or in the other OPCO Transaction Documents, except for a required
notice to the Office of the Chief Scientist of Israel and required filings with the Israeli Companies Registrar, the SEC and the
applicable state securities commissions relating specifically to the Offering (all of which filings will be duly made), other
than those which are required to be made after the First Closing (all of which will be duly made on a timely basis). 

 

(p)
Subsequent to the respective dates as of which information is given in the Memorandum, OPCO has operated its business in the ordinary
course and, except as may otherwise be set forth in the Memorandum, there has been no: (i) OPCO Material Adverse Effect; (ii)
transaction otherwise than in the ordinary course of business consistent with past practice; (iii) issuance of any securities
(debt or equity) or any rights to acquire any such securities other than pursuant to equity incentive plans approved by its Board
of Directors; (iv) damage, loss or destruction, whether or not covered by insurance, with respect to any asset or property of
OPCO; or (v) agreement to permit any of the foregoing.

 

(q)
Except as set forth in the Memorandum, there are no actions, suits, claims, hearings or proceedings pending before any court or
governmental authority or, to the knowledge of OPCO, threatened, against OPCO, or involving its assets or any of its officers
or directors (in their capacity as such) which, if determined adversely to OPCO or such officer or director, could reasonably
be expected to have an OPCO Material Adverse Effect or adversely affect the transactions contemplated by this Agreement or the
Share Exchange Agreement or the enforceability thereof.

 

    	 	-8-	 

    	 	 	 

    

 

(r)
OPCO is not: (i) in violation of its Fourth Amended and Restated Articles of Incorporation; (ii) in default of any indenture,
mortgage, deed of trust, note or other agreement or instrument to which OPCO is a party or by which it is or may be bound or to
which any of its assets may be subject, the default of which could reasonably be expected to have an OPCO Material Adverse Effect;
(iii) in violation of any statute, rule or regulation applicable to OPCO, the violation of which would have an OPCO Material Adverse
Effect; or (iv) in violation of any judgment, decree or order of any court or governmental body having jurisdiction over OPCO
and specifically naming OPCO, which violation or violations individually, or in the aggregate, could reasonably be expected to
have an OPCO Material Adverse Effect.

 

(s)
Except as disclosed in the Memorandum, as of the date of this Agreement, no current or former stockholder, director, officer or
employee of OPCO, nor, to the knowledge of OPCO, any affiliate of any such person is presently, directly or indirectly through
his affiliation with any other person or entity, a party to any loan from OPCO or any other transaction (other than as an employee)
with OPCO providing for the furnishing of services by, or rental of any personal property from, or otherwise requiring cash payments
to any such person.

 

(t)
OPCO has filed, on a timely basis, each federal, state, local and foreign tax return, report and declarations that were required
to be filed, or has requested an extension therefor and has paid all taxes and all related assessments, charges, penalties and
interest to the extent that the same have become due. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of OPCO know of no basis for any such claim. OPCO has not executed a waiver
with respect to the statute of limitations relating to the assessment or collection of any foreign, federal, state or local tax.
To OPCO’ knowledge, none of OPCO’ tax returns is presently being audited by any taxing authority. No liens have been
filed and no claims are being asserted by or against OPCO with respect to any taxes (other than liens for taxes not yet due and
payable). OPCO has not received notice of assessment or proposed assessment of any taxes claimed to be owed by it or any other
Person on its behalf. OPCO is not a party to any tax sharing or tax indemnity agreement or any other agreement of a similar nature
that remains in effect. OPCO has complied in all material respects with all applicable legal requirements relating to the payment
and withholding of taxes and, within the time and in the manner prescribed by law, has withheld from wages, fees and other payments
and paid over to the proper governmental or regulatory authorities all amounts required.

 

(u)
Neither OPCO, nor any director, officer, agent, employee or other Person acting on behalf of OPCO has, in the course of its actions
for, or on behalf of, OPCO (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses
relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official
or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act
of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to
any foreign or domestic government official or employee.

 

    	 	-9-	 

    	 	 	 

    

 

(v)
Except as set forth on Schedule A attached hereto, OPCO is not obligated to pay, and has not obligated the Placement Agent to
pay, a finder’s or origination fee in connection with the Offering (other than to the Placement Agent), and hereby agrees
to indemnify the Placement Agent from any such claim made by any other person, as more fully set forth in Section 8 hereof. Except
as set forth in the Memorandum, OPCO has not offered for sale or solicited offers to purchase the Units except for negotiations
with the Placement Agent.

 

(w)
Neither the sale of the Units by the Issuer nor the Company’s use of the proceeds thereof will violate the Trading with
the Enemy Act, as amended, or any of the foreign assets control regulations of the United States Treasury Department (31 CFR,
Subtitle B, Chapter V, as amended) or any enabling legislation or executive order relating thereto. Without limiting the foregoing,
OPCO is not (a) a person whose property or interests in property are blocked pursuant to Section 1 of Executive Order 13224 of
September 23, 2001 Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism
(66 Fed. Reg. 49079 (2001)) or (b) a person who engages in any dealings or transactions, or be otherwise associated, with any
such person. OPCO is in compliance, in all material respects, with the USA Patriot Act of 2001 (signed into law October 26, 2001).

 

(x)
Until the Termination Date, OPCO will not issue any press release, grant any interview, or otherwise communicate with the media
in any manner whatsoever with respect to the Offering without the Placement Agent’s prior consent, which consent will not
unreasonably be withheld, delayed or conditioned.

 

(y)
Neither OPCO nor any OPCO Related Persons (as defined below) are subject to any of the disqualifications set forth in Rule 506(d)
of Regulation D (each a “Disqualification Event”). OPCO has
exercised reasonable care to determine whether any OPCO Related Person (as defined below) is subject to a Disqualification Event.
The Memorandum contains a true and complete description of the matters required to be disclosed with
respect to OPCO and OPCO Related Persons pursuant to the disclosure requirements of Rule 506(e) of Regulation D, to the extent
applicable. As used herein, “OPCO Related Persons” means any predecessor of OPCO, any affiliated issuer, any
director, executive officer, other officer of OPCO participating in the Offering, any general partner or managing member of OPCO,
any beneficial owner of 20% or more of OPCO’s outstanding voting equity securities, calculated on the basis of voting power,
and any “promoter” (as defined in Rule 405 under the Act) connected with OPCO in any capacity. OPCO agrees to promptly
notify the Placement Agent in writing of (i) any Disqualification Event relating to any OPCO Related Person and (ii) any event
that would, with the passage of time, become a Disqualification Event relating to any OPCO Related Person.

 

(z)
Incorporation by Reference. For the benefit of the Placement Agent, OPCO hereby incorporates by reference all of the representations
and warranties contained in Article II, and its covenants contained in Article V, of the Share Exchange Agreement, in each case
with the same force and effect as if specifically set forth herein.

 

    	 	-10-	 

    	 	 	 

    

 

(aa)
Disclosure. No representation or warranty contained in Section 2 of this Agreement contains any untrue statement of a material
fact or omits to state a material fact necessary to make the statements herein not misleading in the context of such representations
and warranties.

 

2A.
Representations, Warranties and Covenants of Issuer. The representations and warranties of Issuer (as used in this Section
2A, “Issuer” refers to Motus GI Holdings, Inc. and its subsidiaries) to the Placement Agent contained in this
Section 2A are true and correct as of the date of this Agreement.

 

(a)
The Memorandum has been prepared in conformity with all applicable laws, and is in compliance in all material respects with Regulation
D, the Act and the requirements of all other Regulations of the SEC relating to offerings of the type contemplated by the Offering,
and the applicable securities laws and the rules and regulations of those jurisdictions wherein the Placement Agent notifies Issuer
that the Units are to be offered and sold. The Units will be offered and sold pursuant to the registration exemptions provided
by Regulation D and Section 4(a)(2) of the Act as a transaction not involving a public offering and the requirements of any other
applicable state securities laws and the respective rules and regulations thereunder in those United States jurisdictions in which
the Placement Agent notifies Issuer that the Units are being offered for sale. None of Issuer, its affiliates, or any person acting
on its or their behalf (other than the Placement Agent, its affiliates or any person acting on its behalf, in respect of which
no representation is made) has taken nor will it take any action that conflicts with the conditions and requirements of, or that
would make unavailable with respect to the Offering, the exemption(s) from registration available pursuant to Rule 506(b) of Regulation
D or Section 4(a)(2) of the Act, or knows of any reason why any such exemption would be otherwise unavailable to it. None of Issuer,
its predecessors or affiliates has been subject to any order, judgment or decree of any court of competent jurisdiction temporarily,
preliminarily or permanently enjoining such person for failing to comply with Section 503 of Regulation D. Issuer has not, for
a period of six months prior to the commencement of the offering of Units, sold, offered for sale or solicited any offer to buy
any of its securities in a manner that would be integrated with the offer and sale of the Units pursuant to this Agreement, would
cause the exemption from registration set forth in Rule 506(b) of Regulation D to become unavailable with respect to the offer
and sale of the Units pursuant to this Agreement in the United States.

 

(b)
Issuer is duly organized and validly existing in good standing under the laws of the jurisdiction in which it was formed, and
has the requisite power and authority to own its properties and to carry on its business as now being conducted. Issuer is not
a participant in any joint venture, partnership or similar arrangement and does not directly or indirectly own any subsidiaries
or otherwise own or hold capital stock or an equity or similar interest in any entity. Issuer is duly qualified as a foreign entity
to do business and is in good standing in every jurisdiction in which its ownership of property or the nature of the business
conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing
would not have an Issuer Material Adverse Effect (as defined below). As used in this Agreement, “Issuer Material Adverse
Effect” means any material adverse effect on the business, properties, assets, operations, results of operations or
condition (financial or otherwise) of Issuer, taken as a whole, or on the transactions contemplated hereby and the other Issuer
Transaction Documents (as defined below) or by the agreements and instruments to be entered into in connection herewith or therewith,
or on the authority or ability of Issuer to perform its obligations under the Issuer Transaction Documents (as defined below).

 

    	 	-11-	 

    	 	 	 

    

 

(c)
As to Issuer only, the Memorandum does not include any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were
made, not misleading: provided, however, the foregoing does not apply to any statements or omissions made solely
in reliance on and in conformity with written information furnished to Issuer by OPCO or the Placement Agent specifically for
use in the preparation thereof. To the knowledge of Issuer, none of the statements, documents, certificates or other items made,
prepared or supplied by Issuer with respect to the transactions contemplated hereby contains an untrue statement of a material
fact or omits to state a material fact necessary to make the statements contained therein not misleading in light of the circumstances
in which they were made. There are no facts, circumstances or conditions which Issuer has not disclosed in the Memorandum and
of which Issuer is aware that could reasonably be expected to have an Issuer Material Adverse Effect. Notwithstanding anything
to the contrary herein, Issuer makes no representation or warranty with respect to any estimates, projections and other forecasts
and plans (including the reasonableness of the assumptions underlying such estimates, projections and other forecasts and plans)
that may have been delivered to the Placement Agent or its representatives by Issuer, except that such estimates, projections
and other forecasts and plans have been prepared in good faith on the basis of assumptions stated therein, which assumptions were
believed to be reasonable at the time of such preparation.

 

(d)
Issuer has all requisite corporate power and authority to conduct its business as presently conducted and as proposed to be conducted
(as described in the Memorandum), to enter into and perform its obligations under this Agreement, the Subscription Agreement,
the Registration Rights Agreement, the Share Exchange Agreement, the Escrow Agreement (as hereinafter defined) and the other agreements
contemplated hereby (this Agreement, the Subscription Agreement, the Registration Rights Agreement, the Share Exchange Agreement,
the Escrow Agreement (as hereinafter defined) and the other agreements contemplated hereby that Issuer is executing and delivering
hereunder are collectively referred to herein as the “Issuer Transaction Documents”), and subject to necessary
Board and stockholder approvals, to issue, sell and deliver the Units, the shares of Common Stock and Preferred Shares underlying
the Units, and the shares of Common Stock issuable upon conversion of the Preferred Shares (the “Conversion Shares”),
exercise of the Exchange Warrants (the “Exchange Warrant Shares”), the Agent Warrants (as defined in Section
3(b)) and the Agent Warrant Shares (as defined in Section 3(b)). Prior to the First Closing, each of the Issuer Transaction Documents
(other than this Agreement, which has already been authorized) will have been duly authorized. This Agreement has been duly authorized,
executed and delivered and constitutes, and each of the other Issuer Transaction Documents, upon due execution and delivery, will
constitute, valid and binding obligations of Issuer, enforceable against Issuer in accordance with their respective terms (i)
except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws
now or hereafter in effect related to laws affecting creditors’ rights generally, including the effect of statutory and
other laws regarding fraudulent conveyances and preferential transfers, and except that no representation is made herein regarding
the enforceability of Issuer’s obligations to provide indemnification and contribution remedies under the securities laws
and (ii) subject to the limitations imposed by general equitable principles (regardless of whether such enforceability is considered
in a proceeding at law or in equity).

 

    	 	-12-	 

    	 	 	 

    

 

(e)
None of the execution and delivery of, or performance by Issuer under this Agreement or any of the other Issuer Transaction Documents
or the consummation of the transactions herein or therein contemplated conflicts with or violates, or will result in the creation
or imposition of, any lien, charge or other encumbrance upon any of the assets of Issuer under any agreement or other instrument
to which Issuer is a party or by which Issuer or its assets may be bound, or any term of the certificate of incorporation or by-laws
of Issuer, or any license, permit, judgment, decree, order, statute, rule or regulation applicable to Issuer or any of its assets,
except in the case of a conflict, violation, lien, charge or other encumbrance (except with respect to Issuer’s certificate
of incorporation or by-laws) which would not, or could not reasonably be expected to, have an Issuer Material Adverse Effect.

 

(f)
As of the date of the First Closing, Issuer will have the authorized and outstanding capital stock as set forth under the heading
“Capitalization” in the Memorandum. All outstanding shares of capital stock of Issuer are duly authorized, validly
issued, fully paid and nonassessable. Except as described in the Memorandum, as of the date of the First Closing: (i) there will
be no outstanding options, stock subscription agreements, warrants or other rights permitting or requiring Issuer or others to
purchase or acquire any shares of capital stock or other equity securities of Issuer or to pay any dividend or make any other
distribution in respect thereof; (ii) there will be no securities issued or outstanding which are convertible into or exchangeable
for any of the foregoing and there are no contracts, commitments or understandings, whether or not in writing, to issue or grant
any such option, warrant, right or convertible or exchangeable security; (iii) no shares of stock or other securities of Issuer
are reserved for issuance for any purpose; (iv) there will be no voting trusts or other contracts, commitments, understandings,
arrangements or restrictions of any kind with respect to the ownership, voting or transfer of shares of stock or other securities
of Issuer, including, without limitation, any preemptive rights, rights of first refusal, proxies or similar rights, and (v) no
person holds a right to require Issuer to register any securities of Issuer under the Act or to participate in any such registration.
As of the date of the First Closing, the issued and outstanding shares of capital stock of Issuer will conform in all material
respects to all statements in relation thereto contained in the Memorandum and the Memorandum describes all material terms and
conditions thereof. All issuances by Issuer of its securities have been, at the times of their issuance, exempt from registration
under the Act and any applicable state securities laws.

 

(g)
Immediately prior to the First Closing, the Shares and Preferred Shares underlying the Units, the Conversion Shares, the Exchange
Warrants, the Exchange Warrant Shares, the Agent Warrants (as defined in section 3(b)) and the Agent Warrant Shares (as defined
in section 3(b)) will have been duly authorized and, when issued and delivered against payment therefor as provided in the Issuer
Transaction Documents, the Shares, the Preferred Shares, the Conversion Shares, the Exchange Warrant Shares and the Agent Warrant
Shares will be validly issued, fully paid and nonassessable. No holder of any of the Shares or Preferred Shares underlying the
Units, the Conversion Shares, the Exchange Warrants, the Exchange Warrant Shares, the Agent Warrants or the Agent Warrant Shares
will be subject to personal liability solely by reason of being such a holder, and, except as described in the Memorandum, none
of the Shares or Preferred Shares underlying the Units, the Conversion Shares, the Exchange Warrants, the Exchange Warrant Shares,
the Agent Warrants or the Agent Warrant Shares are subject to preemptive or similar rights of any stockholder or security holder
of Issuer or an adjustment under the antidilution or exercise rights of any holders of any outstanding shares of capital stock,
options, warrants or other rights to acquire any securities of Issuer. Immediately prior to the First Closing, a sufficient number
of authorized but unissued shares of Common Stock will have been reserved for issuance upon the conversion of the Preferred Shares
and the exercise of the Exchange Warrants and the Agent Warrants.

 

    	 	-13-	 

    	 	 	 

    

 

(h)
No consent, authorization or filing of or with any court or governmental authority is required in connection with the issuance
or the consummation of the transactions contemplated herein or in the other Issuer Transaction Documents, except for required
filings with the SEC and the applicable state securities commissions relating specifically to the Offering (all of which filings
will be duly made by, or on behalf of, Issuer), other than those which are required to be made after the First Closing (all of
which will be duly made on a timely basis).

 

(i)
Subsequent to the respective dates as of which information is given in the Memorandum, Issuer has operated its business in the
ordinary course and, except as may otherwise be set forth in the Memorandum, there has been no: (i) Issuer Material Adverse Effect;
(ii) transaction otherwise than in the ordinary course of business consistent with past practice; (iii) issuance of any securities
(debt or equity) or any rights to acquire any such securities other than pursuant to equity incentive plans approved by its Board
of Directors; (iv) damage, loss or destruction, whether or not covered by insurance, with respect to any asset or property of
Issuer; or (v) agreement to permit any of the foregoing.

 

(j)
Except as set forth in the Memorandum, there are no actions, suits, claims, hearings or proceedings pending before any court or
governmental authority or, to the knowledge of Issuer, threatened, against Issuer, or involving its assets or any of its officers
or directors (in their capacity as such) which, if determined adversely to Issuer or such officer or director, could reasonably
be expected to have an Issuer Material Adverse Effect or adversely affect the transactions contemplated by this Agreement or the
Share Exchange Agreement or the enforceability thereof.

 

(k)
Other than as set forth on Schedule A attached hereto, Issuer is not obligated to pay, and has not obligated the Placement Agent
to pay, a finder’s or origination fee in connection with the Offering (other than to the Placement Agent), and hereby agrees
to indemnify the Placement Agent from any such claim made by any other person, as more fully set forth in Section 8 hereof. Issuer
has not offered for sale or solicited offers to purchase the Units except for negotiations with the Placement Agent. Except as
set forth in the Memorandum and as previously disclosed to the Placement Agent, no other person has any right to participate in
any offer, sale or distribution of Issuer’s securities to which the Placement Agent’s rights, described herein, shall
apply.

 

    	 	-14-	 

    	 	 	 

    

 

(l)
Neither the sale of the Units by Issuer nor its use of the proceeds thereof will violate the Trading with the Enemy Act, as amended,
or any of the foreign assets control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter V, as amended)
or any enabling legislation or executive order relating thereto. Without limiting the foregoing, Issuer is not (a) a person whose
property or interests in property are blocked pursuant to Section 1 of Executive Order 13224 of September 23, 2001 Blocking Property
and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism (66 Fed. Reg. 49079 (2001)) or
(b) a person who engages in any dealings or transactions, or be otherwise associated, with any such person. Issuer and its subsidiaries,
if any, are in compliance, in all material respects, with the USA Patriot Act of 2001 (signed into law October 26, 2001).

 

(m)
Until the earlier of (i) the Termination Date and (ii) the Final Closing (as defined below), Issuer will not issue any press release,
grant any interview, or otherwise communicate with the media in any manner whatsoever with respect to the Offering without the
Placement Agent’s prior consent, which consent will not unreasonably be withheld, delayed or conditioned.

 

(n)
Subsequent to the Share Exchange Transaction, the Issuer shall establish internal accounting controls sufficient to provide reasonable
assurances that (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability
for assets; (iii) access to assets is permitted only in accordance with management’s general or specific authorization;
and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action
is taken with respect to any differences.

 

(o)
Subsequent to the Share Exchange Transaction, the Issuer shall establish “disclosure controls and procedures” (as
such term is defined in Rule 13a-15I and 15d-15I under the Securities Exchange Act of 1934, as amended, (the “Exchange
Act”)), which (i) are designed to ensure that material information relating to Issuer is made known to Issuer’s
principal executive officer and its principal financial officer by others within those entities, particularly during the periods
in which the periodic reports required under the Exchange Act are being prepared, and (ii) such disclosure controls and procedures
are effective to perform the functions for which they were established. Issuer is not aware of any fraud, whether or not material,
that involves management or other employees who have a role in Issuer’s internal controls.

 

(p)
Neither Issuer nor any Issuer Related Persons (as defined below) are subject to any Disqualification Event. Issuer has exercised
reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Memorandum contains
a true and complete description of the matters required to be disclosed with respect to Issuer and Issuer Related Persons (as
defined below) pursuant to the disclosure requirements of Rule 506I of Regulation D, to the extent applicable. As used herein,
“Issuer Related Persons” means any predecessor of Issuer, any affiliated issuer, any director, executive officer,
other officer of Issuer participating in the Offering, any general partner or managing member of Issuer, any beneficial owner
of 20% or more of Issuer’s outstanding voting equity securities, calculated on the basis of voting power, and any “promoter”
(as defined in Rule 405 under the Act) connected with Issuer in any capacity. Issuer agrees to promptly notify the Placement Agent
in writing of (i) any Disqualification Event relating to any Issuer Related Person and (ii) any event that would, with the passage
of time, become a Disqualification Event relating to any Issuer Related Person.

 

    	 	-15-	 

    	 	 	 

    

 

(q)
Incorporation by Reference. For the benefit of the Placement Agent, Issuer hereby incorporates by reference all of the
representations and warranties contained in Article III, and its covenants contained in Article V, of the Share Exchange Agreement,
in each case with the same force and effect as if specifically set forth herein.

 

(r)
Disclosure. No representation or warranty contained in Section 2A of this Agreement contains any untrue statement of a
material fact or omits to state a material fact necessary to make the statements herein not misleading in the context of such
representations and warranties.

 

2B.
Representations, Warranties and Covenants of Placement Agent. The Placement Agent represents and warrants to OPCO and Issuer
that the following representations and warranties are true and correct as of the date of this Agreement:

 

(a)
Aegis is a corporation duly organized, validly existing and in good standing under the laws of the State of New York and has all
requisite corporate power and authority to enter into this Agreement and to carry out and perform its obligations under the terms
of this Agreement.

 

(b)
This Agreement has been duly authorized, executed and delivered by the Placement Agent, and upon due execution and delivery by
OPCO and Issuer, this Agreement will be a valid and binding agreement of the Placement Agent enforceable against it in accordance
with its terms, except as may be limited by principles of public policy and, as to enforceability, subject to applicable bankruptcy,
insolvency, reorganization, moratorium and similar laws relating to or affecting creditor’s rights from time to time in
effect and subject to general equity principles.

 

(c)
None of the execution and delivery of or performance by Placement Agent under this Agreement or any other agreement or document
entered into by Placement Agent in connection herewith or the consummation of the transactions herein or therein contemplated
conflicts with or violates, any agreement or other instrument to which the Placement Agent is a party or by which its assets may
be bound, or any term of its certificate of incorporation or by-laws, or any license, permit, judgment, decree, order, statute,
rule or regulation applicable to Placement Agent or any of its assets, except in each case as would not have a material adverse
effect on the transactions contemplated hereby.

 

(d)
The Placement Agent is a member in good standing of FINRA and is registered as a broker-dealer under the Exchange Act, and under
the securities acts of each state into which it is making offers or sales of the Units. The Placement Agent is in compliance with
all applicable rules and regulations of the SEC and FINRA, except to the extent that such noncompliance would not have a material
adverse effect on the transactions contemplated hereby. None of the Placement Agent or its affiliates, or any person acting on
behalf of the foregoing (other than Issuer, OPCO, its or their affiliates or any person acting on its or their behalf, in respect
of which no representation is made) has taken nor will it take any action that conflicts with the conditions and requirements
of, or that would make unavailable with respect to the Offering, the exemption(s) from registration available pursuant to Rule
506 of Regulation D or Section 4(a)(2) of the Act, or knows of any reason why any such exemption would be otherwise unavailable
to it.

 

    	 	-16-	 

    	 	 	 

    

 

(e)
Neither Placement Agent nor any Placement Agent Related Persons (as defined below) are subject to any Disqualification Event as
of the date hereof. Placement Agent has exercised reasonable care to determine whether any Placement Agent Related Person (as
defined below) is subject to such a Disqualification Event. The Memorandum contains a true and complete description of the matters
required to be disclosed with respect to Placement Agent and Placement Agent Related Persons (as defined below) pursuant to the
disclosure requirements of Rule 506I of Regulation D, to the extent applicable. As used herein, “Placement Agent Related
Persons” means any predecessor of Placement Agent, any affiliated issuer, any director, executive officer, other officer
of Placement Agent participating in the Offering, any general partner or managing member of Issuer, any beneficial owner of 20%
or more of Placement Agent’s outstanding voting equity securities, calculated on the basis of voting power, and any “promoter”
(as defined in Rule 405 under the Act) connected with Placement Agent in any capacity. Placement Agent agrees to promptly notify
OPCO and Issuer in writing of (i) any Disqualification Event relating to any Placement Agent Related Person and (ii) any event
that would, with the passage of time, become a Disqualification Event relating to any Placement Agent Related Person.

 

(f)
Disclosure. As to Placement Agent only, the Memorandum does not include any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading; provided, however, the foregoing does not apply to any statements or
omissions made solely in reliance on and in conformity with written information furnished to Placement Agent by OPCO or Issuer
specifically for use in the preparation thereof.

 

(g)
Litigation. There are no actions, suits, claims, hearings or proceedings pending before any court or governmental authority
or, to the knowledge of Placement Agent, threatened, against Placement Agent or involving its assets or to the knowledge of Placement
Agent, any of its officers or directors (in their capacity as such) which, if determined adversely to Placement Agent or such
officer or director, could reasonably be expected to adversely affect Placement Agent’s ability to perform its obligations
hereunder.

 

3.
Placement Agent Compensation.

 

(a)
In connection with the Offering, the Issuer will pay at each Closing (as defined in Section 4I below) a cash fee (the “Agent
Cash Fee”) to the Placement Agent equal to 10% of the gross proceeds from the sale of the Units consummated at such
Closing (subject to reduction at the sole discretion of the Placement Agent; provided, however, that no cash commission
shall be paid with respect to (i) the exchange for Units of Convertible Notes issued to the holders before November 7, 2016 and
Perceptive Advisors (collectively, the “Old Notes”) and any Convertible Notes for which the Placement Agent
was previously paid a cash commission and (ii) investments in the Offering made by (x) current shareholders of OPCO, (y) Perceptive
Advisors and (z) certain other investors as set forth on Schedule B1 and B2 hereto. The Placement Agent will also receive the
right for designees of the Placement Agent to receive payments from the Issuer aggregating 10% of the amount of payments paid
to the holders of the Preferred Shares sold in this Offering as a result of such holders’ Royalty Payment Rights, such payments
to be made at the same time as payments are made to the holders of the Royalty Payment Rights.

 

    	 	-17-	 

    	 	 	 

    

 

(b)
As additional compensation, at or within ten
(10) business days following the Final Closing, the Issuer will issue to the Placement Agent (or its designee(s)) for nominal
consideration, warrants (the “Agent Warrants”) to purchase shares of Common Stock (the shares of Common Stock
issuable upon exercise of the Agent Warrants are hereinafter referred to as the “Agent Warrant Shares”). The
Agent Warrants shall be exercisable for that number of shares of Common Stock equaling 10% of the number of shares of Common Stock
(i) included in the Units sold or exchanged at all closings (excluding all Units exchanged for Old Notes), and (ii) underlying
the Preferred Shares included in the Units sold or exchanged at all Closings (as defined below) (excluding all Units exchanged
for Old Notes), at an exercise price of $5.00 per share. There will be no Agent Warrants issued with respect to any Units purchased
by any of the investors set forth on Schedule B1 and B2 hereto; provided, however, that Agent Warrants shall be issued
in connection with the Units purchased by Perceptive Advisors in the Offering as agreed to by the Issuer and the Placement Agent.
The Agent’s Warrants shall be exercisable until the date that is five (5) years after the First Closing, shall contain immediate
cashless exercise provisions and shall not be callable by the Issuer. The Agent Cash Fee and Agent Warrants are sometimes referred
to herein collectively as “Agent Compensation.” The Agent Warrants will be in
such authorized denominations and will be registered in such names as the Placement Agent shall request in an instruction letter
(the “Agent Warrant Instruction Letter”) to be delivered to the Issuer following the Final Closing and the
Issuer shall deliver such Agent Warrants to the Placement Agent within ten (10) business days following the delivery of the Agent
Warrant Instruction Letter.

 

(c)
At each Closing (as defined in section 4I below), the Issuer will pay Aegis a non-accountable expense allowance equal to 3% of
the gross proceeds from the sale of the Units consummated at such Closing (the “Agent Expense Allowance”),
provided that the Agent Expense Allowance shall be reduced to 1.5% with respect to investments made by existing stockholders of
OPCO, Perceptive Advisors, and certain other institutional investors as agreed by the Company and Aegis as set forth on Schedules
B1 and B2 hereto provided further that no expense allowance shall be paid with respect to the exchange for Units of the Convertible
Notes. The Placement Agent will not bear any of Issuer’s or OPCO’s respective legal, accounting, printing or other
expenses in connection with any transaction contemplated hereby. Aegis will pay for its own expenses, including its legal fees
and expenses, from the Agent Expense Allowance. The Agent Expense Allowance will be reduced by the $25,000 paid by OPCO to the
Placement Agent’s counsel upon the execution and delivery of the term sheet with respect to the Share Exchange and the Offering.

 

    	 	-18-	 

    	 	 	 

    

 

(d)
The Issuer shall also pay and issue to the Placement Agent the Agent Compensation calculated according to the percentages set
forth in Sections 3(a) and (b) of this Agreement, if any person or entity contacted by the Placement Agent and provided with a
Memorandum during the Offering Period (other than existing shareholders of OPCO and the investors set forth on Schedules B1 and
B2 hereto) and with whom the Placement Agent has discussions regarding a potential investment in the Offering, invests in the
Issuer (other than through open market purchases or securities purchased in any underwritten public offering) and irrespective
of whether such potential investor purchased Units in the Offering (the “Tail Investors”) at any time prior
to the earlier of the date that is twelve (12) months after the Termination Date or the Final Closing (“Tail Period”),
whichever is applicable; provided, however, that the Tail Period shall terminate immediately in the event that Adam K. Stern is
no longer employed by the Placement Agent at any time during the Tail Period. The names of Tail Investors shall be provided in
writing by the Placement Agent to the Issuer upon written request within 10 days following the Termination Date or the Final Closing,
as the case may be (the “Tail Investor List”); provided, that such Tail Investor List shall include persons
or entities that actually received a copy of the Memorandum. The Company acknowledges and agrees that the Tail Investor List is
proprietary to the Placement Agent, shall be maintained in strict confidence by the Company and those persons/entities on such
list shall not be contacted by the Company without the Placement Agent’s prior written consent; provided, however, that
such restrictions shall not apply to ordinary course stockholder communications by the Company to its stockholders, including
those Tail Investors that are stockholders of the Company. In the event the Placement Agent exercises its ROFR (as defined below)
with respect to an offering pursuant to the provisions of Section 3(f), the specific compensation terms to the Placement Agent
that are negotiated in such offering shall govern and the provisions of this Section 3(d) will not be operative with respect to
such offering.

 

(e)
[Reserved]

 

(f)
Effective as of the First Closing, the Issuer hereby grants to Aegis, subject to Adam K. Stern’s continued employment by
Aegis during the ROFR Term (as hereinafter defined), for a period of twelve (12) months following the Final Closing (the “ROFR
Term”), the irrevocable preferential right of first refusal (“ROFR”) solely to act as lead placement
agent for any proposed private placement pursuant to Regulation D of the Issuer’s securities (equity or debt, but excluding
any institutional bank debt and any securities sold directly to investors without the assistance of a registered broker-dealer);
provided, that such ROFR shall not apply to any offering of securities registered with the SEC and that the ROFR Term will terminate
immediately in the event that Adam K. Stern is no longer employed by the Placement Agent at any time during the ROFR Term. In
that regard, it is understood that if the Issuer determines to pursue a private placement financing pursuant to Regulation D during
the ROFR Term in which a third party placement agent will be engaged, the Issuer shall promptly provide Aegis with a written notice
of such intention and statement of terms (the “Notice”). If, within ten (10) business days of the receipt of
the Notice, Aegis does not accept in writing such offer to act as lead placement agent with respect to such private placement
upon the terms proposed, then the Issuer shall be entitled to engage a placement agent other than Aegis; provided that the terms
of the compensation to be paid to such other placement agent are not materially less favorable to the Issuer than the terms included
in the Notice. Aegis’s failure to exercise these preferential rights in any situation shall not affect its preferential
rights to any subsequent private placement during the ROFR Term. Each of OPCO and the Issuer represent and warrant that no other
person has any right to participate in any offer, sale or distribution of OPCO’s or the Issuer’s securities to which
Aegis’s preferential rights shall apply.

 

    	 	-19-	 

    	 	 	 

    

 

(g)
At the First Closing, the Issuer and the Placement Agent shall enter into a non-exclusive Finder’s Fee Agreement (the “Finder’s
Agreement”), which will provide that, during the three (3) year period following the later of the Termination Date or
the First Closing, if the Company or any of its affiliates shall enter into any of the transactions enumerated in the Finder’s
Agreement (such transactions to include business combinations, joint ventures, license agreements and related transactions) with
any party introduced to the Company by the Placement Agent, then the Company shall pay or cause to be paid to the Placement Agent
a cash finder’s fee (the “Finder’s Fee”) payable in cash at the closing of such transaction, equal
to 5% of the first $1 million of consideration paid by or to the Company, plus 4% of the next $1 million of consideration paid
by or to the Company, plus 3% of the next $5 million of the consideration paid by or to the Company, plus 2.5% of any consideration
paid by or to the Company in excess of $7 million; provided, however, that the Placement Agent will not be entitled
to a finder’s fee entered into with any party with whom the Company had a pre-existing relationship prior to the date of
the specific introduction (including situations where the Company had previously been introduced to such party by someone other
than the Placement Agent or a party with whom the Company had already commenced discussions).

 

(h)
The Company hereby grants the Placement Agent the right to appoint one (1) member of the Company’s board of directors (the
“Aegis Director”) effective as of the First Closing of the Offering. The initial Aegis Director shall be Samuel
Nussbaum, with any successor Aegis Director chosen by the Placement Agent to be subject to the reasonable approval of the Company.
The Aegis Director shall be entitled to (i) the same indemnification protections afforded to other directors of the Company, including
the Company’s continued maintenance of an insurance policy providing liability insurance for directors and officers of the
Company, and (ii) cash and equity compensation in amounts to be determined based on the amounts made available to other non-employee
directors of the Company. This provision shall terminate two years from the Final Closing.

 

(i)
Notwithstanding any other provision of this Section 3, in no event shall the Placement Agent contact any of the investors set
forth on Schedule B2 hereto for the purpose of (i) subscribing for Units in this Offering or (ii) any other investment in Issuer
within twelve (12) months from the date of this Agreement (but the Placement Agent may contact such investors for purposes not
relating to sub-clause (i) or (ii)) as a third-party has the right to receive commissions from OPCO in the event that such investors
invest in the OPCO for any reason during a certain period of time, all of which has been previously disclosed to the Placement
Agent. In the event any investor on Schedule B2 acquires Units in this Offering, any fee, cash or otherwise, payable to the Placement
Agent hereunder shall be reduced by any payment paid by OPCO or the Company to such third party.

 

    	 	-20-	 

    	 	 	 

    

 

4.
Subscription and Closing Procedures.

 

(a)
OPCO and Issuer shall cause to be delivered to the Placement Agent copies of the Memorandum and have each consented, and hereby
consent, to the use of such copies for the purposes permitted by the Act and applicable securities laws and in accordance with
the terms and conditions of this Agreement, and hereby each authorize the Placement Agent and its agents and employees to use
the Memorandum in connection with the offering of the Units until the earlier of (i) the Termination Date or (ii) the Final Closing,
and no person or entity is or will be authorized to give any information or make any representations other than those contained
in the Memorandum or to use any offering materials other than those contained in the Memorandum in connection with the sale of
the Units.

 

(b)
During the Offering Period, OPCO and Issuer shall make available to the Placement Agent and its representatives such information
as may be reasonably requested in making a reasonable investigation of OPCO and Issuer and their respective affairs and shall
provide access to such employees during normal business hours as shall be reasonably requested by the Placement Agent.

 

(c)
Each prospective purchaser will be required to complete and execute an original omnibus signature page, for each of the Subscription
Agreement and the Registration Rights Agreement (the “Subscription Documents”), which will be forwarded or
delivered to the Placement Agent at the Placement Agent’s offices at the address set forth in Section 12 hereof, together
with the subscriber’s wire transfer in the full amount of the purchase price for the number of Units desired to be purchased,
subject to the Escrow Agent’s (as defined below) right to accept a check in lieu of a wire transfer.

 

(d)
All funds for subscriptions received by the Placement Agent from the Offering (not otherwise wired directly to the Escrow Agent)
will be promptly forwarded by the Placement Agent and deposited into a non-interest bearing escrow account (the “Escrow
Account”) established for such purpose with Signature Bank (the “Escrow Agent”). All such funds for
subscriptions will be held in the Escrow Account pursuant to the terms of an escrow agreement among Issuer, OPCO, the Placement
Agent and the Escrow Agent. The Company will pay all fees related to the establishment and maintenance of the Escrow Account.
Subject to the receipt of subscriptions for the Minimum Amount, the Company will either accept or reject, for any or no reason,
the Subscription Documents in a timely fashion and at each Closing, Issuer and OPCO will countersign the Subscription Documents
and provide duplicate copies of such documents to the Placement Agent for distribution to the subscribers. The Placement Agent
on the Company’s behalf, will promptly return to subscribers incomplete, improperly completed, improperly executed and rejected
subscriptions.

 

(e)
If subscriptions for at least the Minimum Amount
have been accepted prior to the Termination Date, which calculation shall include the exchange of the Convertible Notes for Units,
the funds therefor have been collected by the Escrow Agent and all of the conditions set forth elsewhere in this Agreement are
fulfilled, the First Closing shall be held promptly with respect to Units sold. Thereafter remaining Units will continue to be
offered and sold until the Termination Date and additional closings (each a “Closing”) may from time to time
be conducted at times mutually agreed to between the Placement Agent and the Company with respect to additional Units sold, with
the final closing (“Final Closing”) to occur within ten (10) days after the earlier of the Termination Date
and the date on which the all Units has been fully subscribed for. Delivery of payment for the accepted subscriptions for Units
from funds held in the Escrow Account will be made at each Closing against delivery of the Shares and Preferred Shares by the
Company. Executed certificates for the Common Stock and Warrants will be made available to the Placement
Agent for checking and packaging at least one business day prior to each Closing. The Company’s transfer agent, to be engaged
prior to the First Closing, shall be instructed by the Company to deliver such Common Stock certificates and Warrants within a
commercially reasonable time after each Closing. 

 

    	 	-21-	 

    	 	 	 

    

 

(f)
If Subscription Documents for the Minimum Amount have not been received and accepted by the Company on or before the Termination
Date for any reason, the Offering will be terminated, no Units will be sold, and the Escrow Agent will, at the request of the
Placement Agent, cause all monies received from subscribers for the Units to be promptly returned to such subscribers without
interest, penalty, expense or deduction.

 

5.
Further Covenants. OPCO and Issuer hereby covenant and agree that:

 

(a)
Except upon prior written notice to the Placement Agent, neither OPCO nor Issuer shall, at any time prior to the Final Closing,
knowingly take any action which would cause any of the representations and warranties made by it in this Agreement not to be complete
and correct in all material respects on and as of the date of each Closing with the same force and effect as if such representations
and warranties had been made on and as of each such date (except to the extent any representation or warranty relates to an earlier
date).

 

(b)
If, at any time prior to the Final Closing, any event shall occur that causes (i) an OPCO Material Adverse Effect or (ii) an Issuer
Material Adverse Effect, either of which as a result it becomes necessary to amend or supplement the Memorandum so that the representations
and warranties herein remain true and correct in all material respects, or in case it shall be necessary to amend or supplement
the Memorandum to comply with Regulation D or any other applicable securities laws or regulations, either OPCO or Issuer, as applicable,
will promptly notify the Placement Agent and shall, at its sole cost, prepare and furnish to the Placement Agent copies of appropriate
amendments and/or supplements in such quantities as the Placement Agent may reasonably request for delivery by the Placement Agent
to potential subscribers. Neither OPCO nor Issuer will at any time before the Final Closing prepare or use any amendment or supplement
to the Memorandum of which the Placement Agent will not previously have been advised and furnished with a copy, or which is not
in compliance in all material respects with the Act and other applicable securities laws. As soon as OPCO or Issuer is advised
thereof, OPCO or Issuer, as applicable, will advise the Placement Agent and its counsel, and confirm the advice in writing, of
any order preventing or suspending the use of the Memorandum, or the suspension of any exemption for such qualification or registration
thereof for offering in any jurisdiction, or of the institution or threatened institution of any proceedings for any of such purposes,
and OPCO and Issuer, as applicable, will use their reasonable best efforts to prevent the issuance of any such order and, if issued,
to obtain as soon as reasonably possible the lifting thereof.

 

    	 	-22-	 

    	 	 	 

    

 

(c)
OPCO and Issuer shall comply with the Act, the Exchange Act and the rules and regulations thereunder, all applicable state securities
laws and the rules and regulations thereunder in the states in which OPCO’s Blue Sky counsel has advised the Placement Agent,
OPCO and/or Issuer that the Units are qualified or registered for sale or exempt from such qualification or registration, so as
to permit the continuance of the sales of the Units, and will file or cause to be filed with the SEC, and shall promptly thereafter
forward or cause to be forwarded to the Placement Agent, any and all reports on Form D as are required.

 

(d)
Issuer shall use best efforts to qualify the Units for sale under the securities laws of such jurisdictions in the United States
as may be mutually agreed to by OPCO, Issuer and the Placement Agent, and Issuer will make or cause to be made such applications
and furnish information as may be required for such purposes, provided that Issuer will not be required to qualify as a foreign
corporation in any jurisdiction or execute a general consent to service of process. Issuer will, from time to time, prepare and
file such statements and reports as are or may be required to continue such qualifications in effect for so long a period as the
Placement Agent may reasonably request with respect to the Offering.

 

(e)
The Issuer shall place a legend on the certificates representing the Shares, the Preferred Shares, the Conversion Shares, the
Exchange Warrants and the Agent Warrants that the securities evidenced thereby have not been registered under the Act or applicable
state securities laws, setting forth or referring to the applicable restrictions on transferability and sale of such securities
under the Act and applicable state laws.

 

(f)
The Company shall apply the net proceeds from the sale of the Units for the purposes substantially as described under the “Use
of Proceeds” section of the Memorandum. Except as set forth in the Memorandum, the Company shall not use any of the net
proceeds of the Offering to repay indebtedness to officers (other than accrued salaries incurred in the ordinary course of business),
directors or stockholders of the Company without the prior written consent of the Placement Agent.

 

(g)
During the Offering Period OPCO or Issuer, as applicable, shall afford each prospective purchaser of Units the opportunity to
ask questions of and receive answers from an officer of OPCO or Issuer concerning the terms and conditions of the Offering and
the opportunity to obtain such other additional information necessary to verify the accuracy of the Memorandum to the extent OPCO
or Issuer possesses such information or can acquire it without unreasonable expense.

 

(h)
Except with the prior written consent of Aegis, which consent shall not be unreasonably withheld, OPCO and Issuer shall not, at
any time prior to the earlier of the Final Closing or the Termination Date, except as contemplated by the Memorandum (i) engage
in or commit to engage in any transaction outside the ordinary course of business as described in the Memorandum, (ii) issue,
agree to issue or set aside for issuance any securities (debt or equity) or any rights to acquire any such securities; provided
that the Company shall be permitted to issue stock options and/or restricted stock units to officers, directors and employees
of the Company as described in the Memorandum; and it being acknowledged and agreed that after the Final Closing or Termination
Date, the Issuer may issue, in its sole discretion, a number of stock options and/or restricted units in the aggregate in an amount
of up to 15% of the fully diluted outstanding shares of the Issuer pursuant to the Issuer’s 2016 Equity Incentive Plan (the
“Plan”), (iii) incur, outside the ordinary course of business, any material indebtedness, (iv) dispose of any
material assets, (v) make any acquisition or (vi) change its business or operations.

 

    	 	-23-	 

    	 	 	 

    

 

(i)
OPCO or the Issuer, as applicable, shall pay all reasonable expenses incurred in connection with the preparation and printing
of all necessary offering documents and instruments related to the Offering and the issuance of the Shares, the Preferred Shares,
the Conversion Shares, the Exchange Warrants and the Agent Warrants and will also pay OPCO’s and the Issuer’s own
expenses for accounting fees, legal fees and other costs involved with the Offering (provided that OPCO shall not be responsible
for the legal fees of Issuer for the period prior to the First Closing other than the $25,000 previously paid to the Placement
Agent’s counsel). OPCO will provide at its own expense such quantities of the Memorandum and other documents and instruments
relating to the Offering as the Placement Agent may reasonably request. All Blue Sky filings related to this Offering shall
be prepared by OPCO’s counsel, on behalf of the Issuer, at OPCO’s expense, with copies of all filings to be promptly
forwarded to the Placement Agent. Further, as promptly as practicable after the Final Closing, the Company shall prepare, at its
own expense, velobound “closing binders” relating to the Offering and will distribute one such binder to each of the
Placement Agent and its counsel.

 

(j)
Until the earlier of the Termination Date or the Final Closing, neither OPCO nor Issuer nor any person or entity acting on such
persons’ behalf will negotiate with any other placement agent or underwriter with respect to a private offering of such
entity’s debt or equity securities. Neither OPCO nor Issuer nor anyone acting on such persons’ behalf will, until
the earlier of the Termination Date or the Final Closing, without the prior written consent of the Placement Agent, offer for
sale to, or solicit offers to subscribe for Units from, or otherwise approach or negotiate in respect thereof with, any other
person.

 

5A.
Placement Agent Further Covenants.

 

The
Placement Agent shall not, at any time during the Offering Period, knowingly take any action which would cause any of the representations
and warranties made by it in this Agreement not to be complete and correct in all material respects on and as of each Closing
Date with the same force and effect as if such representations and warranties had been made on and as of each such date (except
to the extent any representation or warranty relates to an earlier date).

 

6.
Conditions of Placement Agent’s Obligations. The obligations of the Placement Agent hereunder to effect a Closing
are subject to the fulfillment, at or before each Closing, of the following additional conditions:

 

(a)
Each of the representations and warranties made by OPCO and Issuer qualified as to materiality shall be true and correct in all
material respects at all times prior to and on each Closing Date, except to the extent any such representation or warranty expressly
speaks as of an earlier date, in which case such representation or warranty shall be true and correct in all material respects
as of such earlier date, and the representations and warranties made by OPCO and Issuer not qualified as to materiality shall
be true and correct in all material respects at all times prior to and on each Closing Date, except to the extent any such representation
or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and correct in
all material respects as of such earlier date.

 

    	 	-24-	 

    	 	 	 

    

 

(b)
OPCO and Issuer (and the Company following the First Closing) shall have performed and complied in all material respects with
all agreements, covenants and conditions required to be performed and complied with by them at or before the Closing.

 

(c)
The Memorandum did not, and as of the date of any amendment or supplement thereto will not, include any untrue statement of a
material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading.

 

(d)
The Company shall have obtained all consents, waivers and approvals required to be obtained by the Company in connection with
the consummation of the transactions contemplated hereby.

 

(e)
No order suspending the use of the Memorandum or enjoining the Offering or sale of the Units shall have been issued, and no proceedings
for that purpose or a similar purpose shall have been initiated or pending, or, to OPCO’s and Issuer’s knowledge,
threatened.

 

(f)
The Placement Agent shall have received a certificate of the Chief Executive Officer of each of OPCO and Issuer, dated as of the
date of the First Closing (Issuer only for subsequent Closings), certifying, as to the fulfillment of the conditions set forth
in subparagraphs (a), (b), (c) and (d) above.

 

(g)
OPCO and Issuer shall have delivered to the Placement Agent: (i) a certified charter document and good standing certificate, each
dated as of a date within ten (10) days prior to the First Closing from the secretary of state of its jurisdiction of incorporation;
and (ii) resolutions of OPCO’s and Issuer’s Board of Directors approving this Agreement and the transactions and agreements
contemplated by this Agreement, the Share Exchange Agreement and the transactions contemplated by the Share Exchange Agreement,
and the Memorandum, certified by the Chief Executive Officer of OPCO and Issuer.

 

(h)
At each Closing, the Company shall pay and/or issue to the Placement Agent the Agent Cash Fee and Agent Expense Allowance earned
in such Closing. Agent Warrants shall be delivered to the Placement Agent in accordance with Section 3(b) hereto.

 

(i)
At the First Closing, (i) OPCO shall deliver to the Placement Agent a signed opinion of Lowenstein Sandler LLP and Fischer Behar
Chen Well Orion & Co., Israeli counsel to OPCO, dated as of the Closing Date, in form
and substance reasonably satisfactory to the Placement Agent and its counsel, and (ii) Issuer shall deliver to the Placement
Agent a signed opinion of Littman Krooks LLP, counsel to Issuer, dated as of the Closing Date in
form and substance reasonably satisfactory to the Placement Agent and its counsel. At all subsequent Closings, the Issuer
shall deliver to the Placement Agent a signed opinion of Lowenstein Sandler LLP and Fischer Behar Chen Well Orion & Co., counsel
to the Company following the First Closing, dated as of the Closing Date, in form and substance reasonably
satisfactory to the Placement Agent.

 

    	 	-25-	 

    	 	 	 

    

 

(j)
All proceedings taken at or prior to any Closing in connection with the authorization, issuance and sale of the Shares, the Preferred
Shares, the Exchange Warrants and the Agent Warrants will be reasonably satisfactory in form and substance to the Placement Agent
and its counsel, and such counsel shall have been furnished with all such documents, certificates and opinions as it may reasonably
request upon reasonable prior notice in connection with the transactions contemplated hereby.

 

(k)
With respect to the First Closing, the Share Exchange per the terms of the Share Exchange Agreement shall have been consummated.

 

(l)
Lock-up agreements with all of the Company’s officers, directors and stockholders owning in the aggregate 5% or more of
the capital stock of the Company immediately prior to the time of the First Closing, in form and substance reasonably acceptable
to the Placement Agent and consistent with the terms set forth in the Memorandum, shall have been executed and delivered to the
Placement Agent.

 

(m)
Employment agreements with Mark Pomeranz, and James Martin in form and substance acceptable to the Placement Agent and as described
in the Memorandum shall be entered into by and between the Issuer and each of Mark Pomeranz and James Martin.

 

7.
Conditions of Issuer’s and OPCO’s Obligations. The obligations of Issuer and OPCO hereunder to effect
the First Closing and the obligations of the Company to effect all subsequent Closings are subject to the fulfillment, at or before
each Closing, of the following additional conditions or subject to the waiver of such condition or conditions by OPCO in which
case the Issuer shall not be permitted to fail to close as a result of non-satisfaction of such condition or conditions that have
been waived by OPCO:

 

(a)
Each of the representations and warranties made by the Placement Agent shall be true and correct at all times prior to and on
each Closing Date.

 

(b)
The Placement Agent shall have performed and complied in all material respects with all agreements, covenants and conditions required
to be performed and complied with by it at or before the Closing.

 

(c)
The Company shall have received a certificate of an officer of the Placement Agent, dated as of the Closing Date, certifying,
as to the fulfillment of the conditions set forth in subparagraphs (a) and (b) above.

 

(d)
No order suspending the use of the Memorandum or enjoining the Offering or sale of the Units shall have been issued, and no proceedings
for that purpose or a similar purpose shall have been initiated or pending, or, to the Company’s knowledge, be contemplated
or threatened.

 

    	 	-26-	 

    	 	 	 

    

 

(e)
Lock-up agreements with all stockholders of Issuer pre-Share Exchange, which include but are not limited to employees and affiliates
of the Placement Agent in form and substance reasonably acceptable to OPCO and consistent with the terms set forth in the Memorandum,
shall have been executed and delivered to OPCO and Issuer.

 

8.
Indemnification.

 

(a)
Issuer and OPCO severally if the Share Exchange does not occur, and jointly and severally following the consummation of the Share
Exchange, will: (i) indemnify and hold harmless the Placement Agent, their agents and their respective officers, directors, employees,
selected dealers and each person, if any, who controls the Placement Agent within the meaning of the Section 15 of the Act or
Section 20(a) of the Exchange Act and such selected dealers (each an “Indemnitee” or a “Placement
Agent Party”) against, and pay or reimburse each Indemnitee for, any and all losses, claims, damages, liabilities or
expenses whatsoever (or actions or proceedings or investigations in respect thereof), joint or several (which will, for all purposes
of this Agreement, include, but not be limited to, all reasonable costs of defense and investigation and all reasonable attorneys’
fees, including appeals), to which any Indemnitee may become subject (x) under the Act or otherwise, in connection with the offer
and sale of the Units and (y) as a result of the breach of any representation, warranty or covenant made by either OPCO or Issuer
herein, regardless of whether such losses, claims, damages, liabilities or expenses shall result from any claim by any Indemnitee
or by any third party; and (ii) reimburse each Indemnitee for any legal or other expenses reasonably incurred in connection with
investigating or defending against any such loss, claim, action, proceeding or investigation; provided, however,
that Issuer and OPCO will not be liable in any such case to the extent that any such claim, damage or liability is finally judicially
determined to have resulted primarily from (A) an untrue statement or alleged untrue statement of a material fact made in the
Memorandum, or an omission or alleged omission to state therein a material fact required to be stated therein or necessary to
make the statements therein not misleading, made solely in reliance upon and in conformity with written information furnished
to Issuer and/or OPCO by the Placement Agent specifically for use in the Memorandum, (B) any violations by the Placement Agent
of the Act, state securities laws or any rules or regulations of FINRA, which does not result from a violation thereof by OPCO,
Issuer, or any of their respective affiliates or (C) the Placement Agent’s willful misconduct or gross negligence. In addition
to the foregoing agreement to indemnify and reimburse, Issuer and OPCO jointly and severally will indemnify and hold harmless
each Indemnitee against any and all losses, claims, damages, liabilities or expenses whatsoever (or actions or proceedings or
investigations in respect thereof), joint or several (which shall, for all purposes of this Agreement, include, but not be limited
to, all reasonable costs of defense and investigation and all reasonable attorneys’ fees, including appeals) to which any
Indemnitee may become subject insofar as such costs, expenses, losses, claims, damages or liabilities arise out of or are based
upon the claim of any person or entity that he or it is entitled to broker’s or finder’s fees from any Indemnitee
in connection with the Offering, other than fees due to the Placement Agent. The foregoing indemnity agreements will be in addition
to any liability Issuer and OPCO may otherwise have.

 

    	 	-27-	 

    	 	 	 

    

 

(b)
The Placement Agent will indemnify and hold harmless Issuer and OPCO, their respective officers, directors, and each person, if
any, who controls such entity within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act against, and pay
or reimburse any such person for, any and all losses, claims, damages, liabilities or expenses whatsoever (or actions, proceedings
or investigations in respect thereof) to which Issuer or OPCO or any such person may become subject under the Act or otherwise,
whether such losses, claims, damages, liabilities or expenses shall result from any claim of Issuer, OPCO or any such person who
controls Issuer or OPCO within the meaning of the Act or by any third party, but only to the extent that such losses, claims,
damages or liabilities results from (i) any untrue statement or alleged untrue statement of any material fact contained in the
Memorandum made in reliance upon and in conformity with information contained in the Memorandum relating to the Placement Agent,
or an omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements
therein not misleading, in either case, if made or omitted in reliance upon and in conformity with written information furnished
to Issuer or OPCO by the Placement Agent, specifically for use in the preparation thereof or (ii) any violations by the Placement
Agent of the Act or state securities laws which does not result from a violation thereof by OPCO, Issuer or any of their respective
affiliates. The Placement Agent will reimburse the Company or any such person for any legal or other expenses reasonably incurred
in connection with investigating or defending against any such loss, claim, damage, liability or action, proceeding or investigation
to which such indemnity obligation applies. The foregoing indemnity agreements are in addition to any liability which the Placement
Agent may otherwise have. Notwithstanding the foregoing, in no event (except in the event of gross negligence or willful misconduct
by the Placement Agent to the extent and only to the extent if found in a final judgment by a court of competent jurisdiction)
shall the Placement Agent’s indemnification obligation hereunder exceed the amount of Agent Cash Fees actually received
by the Placement Agent.

 

(c)
Promptly after receipt by an indemnified party under this Section 8 of notice of the commencement of any action, claim, proceeding
or investigation (the “Action”), such indemnified party, if a claim in respect thereof is to be made against
the indemnifying party under this Section 8, will notify the indemnifying party of the commencement thereof, but the omission
to so notify the indemnifying party will not relieve it from any liability that it may have to any indemnified party under this
Section 8 unless the indemnifying party has been substantially prejudiced by such omission. The indemnifying party will be entitled
to participate in and, to the extent that it may wish, jointly with any other indemnifying party, to assume the defense thereof
subject to the provisions herein stated, with counsel reasonably satisfactory to such indemnified party. The indemnified party
will have the right to employ separate counsel in any such Action and to participate in the defense thereof, but the fees and
expenses of such counsel will not be at the expense of the indemnifying party if the indemnifying party has assumed the defense
of the Action with counsel reasonably satisfactory to the indemnified party, provided, however, that if the indemnified
party shall be requested by the indemnifying party to participate in the defense thereof or shall have concluded in good faith
and specifically notified the indemnifying party either that there may be specific defenses available to it that are different
from or additional to those available to the indemnifying party or that such Action involves or could have a material adverse
effect upon it with respect to matters beyond the scope of the indemnity agreements contained in this Agreement, then the counsel
representing it, to the extent made necessary by such defenses, shall have the right to direct such defenses of such Action on
its behalf and in such case the reasonable fees and expenses of such counsel in connection with any such participation or defenses
shall be paid by the indemnifying party. No settlement of any Action against an indemnified party will be made without the consent
of the indemnifying party and the indemnified party, which consent shall not be unreasonably withheld, delayed or conditioned
in light of all factors of importance to such party, and no indemnifying party shall be liable to indemnify any person for any
settlement of any such claim effected without such indemnifying party’s consent.

 

    	 	-28-	 

    	 	 	 

    

 

9.
Contribution. To provide for just and equitable contribution, if: (i) an indemnified party makes a claim for indemnification
pursuant to Section 8 hereof and it is finally determined, by a judgment, order or decree not subject to further appeal that such
claims for indemnification may not be enforced, even though this Agreement expressly provides for indemnification in such case;
or (ii) any indemnified or indemnifying party seeks contribution under the Act, the Exchange Act, or otherwise, then each indemnifying
party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect
not only such relative benefits but also the relative fault of the Company on the one hand and the Placement Agent on the other
in connection with the statements or omissions which resulted in such losses, claims, damages, liabilities or expenses (or actions
in respect thereof), as well as any other relevant equitable considerations. The relative benefits received by the Company on
the one hand and the Placement Agent on the other shall be deemed to be in the same proportion as the total net proceeds from
the Offering (before deducting expenses) received by the Company bear to the total Agent Cash Fees received by the Placement Agent.
The relative fault, in the case of an untrue statement, alleged untrue statement, omission or alleged omission will be determined
by, among other things, whether such statement, alleged statement, omission or alleged omission relates to information supplied
by the Company or by the Placement Agent, and the parties’ relative intent, knowledge, access to information and opportunity
to correct or prevent such statement, alleged statement, omission or alleged omission. The Company and the Placement Agent agree
that it would be unjust and inequitable if the respective obligations of the Company and the Placement Agent for contribution
were determined by pro rata allocation of the aggregate losses, liabilities, claims, damages and expenses or by any other
method or allocation that does not reflect the equitable considerations referred to in this Section 9. No person guilty of a fraudulent
misrepresentation (within the meaning of Section 10(f) of the Act) will be entitled to contribution from any person who is not
guilty of such fraudulent misrepresentation. For purposes of this Section 9, each person, if any, who controls the Placement Agent
within the meaning of the Act will have the same rights to contribution as the Placement Agent, and each person, if any, who controls
the Company within the meaning of the Act will have the same rights to contribution as the Company, subject in each case to the
provisions of this Section 9. Anything in this Section 9 to the contrary notwithstanding, no party will be liable for contribution
with respect to the settlement of any claim or action effected without its written consent. This Section 9 is intended to supersede,
to the extent permitted by law, any right to contribution under the Act, the Exchange Act or otherwise available.

 

    	 	-29-	 

    	 	 	 

    

 

10.
Termination.

 

(a)
The Offering may be terminated by the Placement Agent at any time prior to the expiration of the Offering Period in the event
that: (i) any of the representations, warranties or covenants of OPCO contained herein or in the Memorandum shall prove to have
been false or misleading in any material respect when actually made; (ii) OPCO shall have failed to perform any of its material
obligations hereunder or under any other OPCO Transaction Document, Issuer Transaction Document or any other transaction document;
(iii) there shall occur any event that could reasonably be expected to result in an OPCO Material Adverse Effect; or (iv) the
Placement Agent determines that it is reasonably likely that any of the conditions to Closing set forth herein will not, or cannot,
be satisfied. In the event of any such termination by the Placement Agent pursuant to clauses (i), (ii) or (iii) of this Section
10(a), the Placement Agent shall be entitled to retain any Agent Compensation already earned (if any, at such point in time) and
receive from OPCO and/or the Issuer, within five (5) business days of the Termination Date, in addition to other rights and remedies
it may have hereunder, at law or otherwise, an amount equal to the sum of $100,000, which shall be offset by the $25,000 the Company
advanced to legal counsel for the Placement Agent if such termination occurs prior to the First Closing (the “Termination
Amount”) and the provisions of Section 3(d) shall survive in full force and effect. In the event of a termination by
the Placement Agent under Section 10(a)(iv) that occurs prior to the First Closing, the Placement Agent shall not be entitled
to any further compensation pursuant to these termination provisions, except for reimbursement of its out-of-pocket legal expenses
incurred in connection with the Offering (not to exceed $50,000 (inclusive of the $25,000 previously paid)) and the provisions
of Section 3(d) shall survive in full force and effect.

 

(b)
This Offering may be terminated by OPCO or the Issuer at any time prior to the expiration of the Offering Period (i) in the event
that the Placement Agent shall have failed to perform any of its material obligations hereunder or (ii) on account of the Placement
Agent’s fraud, willful misconduct or gross negligence. In the event of any such termination pursuant to this Section 10(b),
the Placement Agent shall not be entitled to any further compensation pursuant to these termination provisions.

 

(c)
In the event OPCO or the Issuer unilaterally decides for any reason (other than pursuant to Section 10(b) above or Section 10(d)
below) to terminate the Offering at any time prior to the First Closing (the “Unilateral Termination”), the
Placement Agent shall be entitled to receive from OPCO $100,000 plus the Placement Agent’s out-of-pocket legal expenses
not to exceed $50,000 in connection with the Offering (inclusive of the $25,000 previously paid) (the “Unilateral Termination
Amount”). In addition, if within twelve (12) months after the Unilateral Termination, the Company conducts a public
or private offering of its securities or enters into a letter of intent with respect to the foregoing, then upon the closing of
any such transaction, the terminating party shall pay the Placement Agent in cash, within five (5) business days of the closing
of any such transaction an amount equal to 2% of the gross proceeds from such private or public offering (the “Additional
Unilateral Termination Amount”), provided that such percentage shall be the applicable percentages set forth in section
3(d) hereto with respect to any gross proceeds from Tail Investors.

 

    	 	-30-	 

    	 	 	 

    

 

(d)
This Offering may be terminated upon mutual agreement of Issuer, OPCO and Aegis, on behalf of the Placement Agent, at any time
prior to the expiration of the Offering Period on terms to be negotiated at such time. In addition, upon the expiration of the
Offering Period, the Offering shall terminate without any further action of the parties hereto. If the Offering is terminated
pursuant to this Section 10(d), then in cases in which no Closing had been theretofore consummated, each party shall pay its own
respective expenses, provided that the $25,000 previously advanced to Aegis’s counsel toward the Expense Allowance shall
be retained by Aegis.

 

(e)
Before any termination by the Placement Agent under Section 10(a) or by OPCO or the Company under Section 10(b) shall become effective,
the terminating party shall give written notice to the other party of its intention to terminate the Offering, which shall set
forth the specific grounds for the proposed termination (the “Termination Notice”). If the specified grounds
for termination, or their resulting adverse effect on the transactions contemplated hereby, are curable, then the other party
shall have ten (10) days from the Termination Notice within which to remove such grounds or to eliminate all of their material
adverse effects on the transactions contemplated hereby; otherwise, the Offering shall terminate.

 

(f)
In the event that a majority of OPCO’s capital stock or assets is sold, or OPCO is merged with or merges with or into another
entity or otherwise combined with or acquired, or enters into a letter of intent or memorandum of understanding with respect to
any of the foregoing, within one year following a Unilateral Termination, then upon the closing of any such transaction, OPCO,
the Company or their successor shall pay the Placement Agent in cash, within five (5) business days of the closing of any such
transaction, an amount equal to 2% of the total consideration received or receivable by OPCO, or any of its officers, directors
or stockholders in connection with such transaction. Notwithstanding the foregoing, however, if an event or transaction shall
occur that would entitle the Placement Agent to receive both the Additional Unilateral Termination Amount and the Finder’s
Fee, then Aegis, on behalf of the Placement Agent may elect which of the two such fees, but may elect only one of such fees, it
shall collect from OPCO, the Company or their successor. In the event that the Placement Agent has elected to receive the Additional
Unilateral Termination Amount in accordance with this Section 10, and subsequently an event or transaction occurs that would have
entitled the Placement Agent to receive a Finder’s Fee in excess of such Additional Unilateral Termination Amount, then
the Placement Agent may require OPCO or the Company to pay it the difference between the Additional Unilateral Termination Amount
already paid and the amount of the Finder’s Fee to which it otherwise would have been entitled to receive from OPCO or the
Company.

 

(g)
Upon any termination pursuant to this Section 10, the applicable parties to this Agreement will instruct Escrow Agent to cause
all monies received with respect to the subscriptions for Units not closed upon to be promptly returned to such subscribers without
interest, penalty or deduction.

 

11.
Survival.

 

(a)
The obligations of the parties to pay any costs and expenses hereunder and to provide indemnification and contribution as provided
herein shall survive any termination hereunder. In addition, the provisions of Sections 3(d), 3(f) (only following a termination
after the First Closing) and 8 through 16 shall survive the sale of the Units or any termination of the Offering hereunder.

 

    	 	-31-	 

    	 	 	 

    

 

(b)
The respective indemnities, covenants, representations, warranties and other statements of Issuer, OPCO and the Placement Agent
set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by
or on behalf of, and regardless of any access to information by, Issuer, OPCO or the Placement Agent, or any of their officers
or directors or any controlling person thereof, and will survive the sale of the Units or any termination of the Offering hereunder
for a period of two (2) years from the earlier to occur of the Final Closing or the termination of the Offering.

 

12.
Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to
have been duly given or made as of the date delivered personally, or the date mailed if mailed by registered or certified mail
(postage prepaid, return receipt requested) to the parties at the following addresses (or at such other address for a party as
shall be specified by like changes of address which shall be effective upon receipt) or sent by facsimile transmission, with confirmation
received, or by electronic mail submission on the date sent, if sent to the Placement Agent, will be mailed, delivered or telefaxed
and confirmed or e-mailed to Aegis Capital Corp., 810 Seventh Ave, 11th Floor, New York, New York 10019, Attention:
Adam K. Stern, telefax number (646) 390-9122, adam@sternaeigs.com, with a copy (which shall not constitute notice) to: Duane Morris
LLP, 1540 Broadway, 14th Floor, New York, NY 10036 Attention: Nanette C. Heide, Esq., telefax number (212) 202-5334,
ncheide@duanemorris.com, if sent to OPCO, will be mailed, delivered, telefaxed and confirmed or emailed to Motus GI Medical Technologies
Ltd., 150 Union Square Drive, New Hope, PA 18938, Attention: Mark Pomeranz, CEO, mark@motusgi.com, with a copy (which shall not
constitute notice) to: Lowenstein Sandler LLP, 1251 Avenue of the Americas, New York, NY 10020, Attn: Steven M. Skolnick, Esq.,
telefax number (973) 597 2477, sskolnick@lowenstein.com, and if sent to Issuer, will be mailed, delivered or telefaxed and confirmed
or e-mailed to Motus GI Holdings, Inc., 142 West 57th St. Suite 4A, New York, NY 10019, Attn: Todd Van Emburgh, President,
vanemburghtodd@yahoo.com, with a copy (which shall not constitute notice) to: Littman Krooks LLP, 655 Third Avenue, 20th
floor, New York, NY 10017 Attention: Steven Uslaner, Esq., telefax number (212) 490-2990, suslaner@littmankrooks.com; provided,
however, that from and after the First Closing, notices to Issuer shall be sent in the same manner, and to the same address,
as notices to OPCO, with a copy (which shall not constitute notice) to: Lowenstein Sandler LLP, 1251 Avenue of the Americas, New
York, NY 10020, Attn: Steven M. Skolnick, Esq., telefax number (973) 597-2477, sskolnick@lowenstein.com.

 

13.
Governing Law, Jurisdiction. This Agreement shall be deemed to have been made and delivered in New York City and shall
be governed as to validity, interpretation, construction, affect and in all other respects by the internal laws of the State of
New York. THE PARTIES AGREE THAT ANY DISPUTE, CLAIM OR CONTROVERSY DIRECTLY OR INDIRECTLY RELATING TO OR ARISING OUT OF THIS
AGREEMENT, THE TERMINATION OR VALIDITY HEREOF, ANY ALLEGED BREACH OF THIS AGREEMENT OR THE ENGAGEMENT CONTEMPLATED HEREBY (ANY
OF THE FOREGOING, A “CLAIM”) SHALL BE SUBMITTED TO THE JUDICIAL ARBITRATION AND MEDIATION SERVICES, INC (“JAMS”),
OR ITS SUCCESSOR, IN NEW YORK, FOR FINAL AND BINDING ARBITRATION IN FRONT OF A PANEL OF THREE ARBITRATORS WITH JAMS IN NEW YORK,
NEW YORK UNDER THE JAMS COMPREHENSIVE ARBITRATION RULES AND PROCEDURES (WITH EACH OF THE PLACEMENT AGENT AND OPCO CHOOSING ONE
ARBITRATOR, AND THE CHOSEN ARBITRATORS CHOOSING THE THIRD ARBITRATOR). THE ARBITRATORS SHALL, IN THEIR AWARD, ALLOCATE ALL OF
THE COSTS OF THE ARBITRATION, INCLUDING THE FEES OF THE ARBITRATORS AND THE REASONABLE ATTORNEYS’ FEES OF THE PREVAILING
PARTY, AGAINST THE PARTY WHO DID NOT PREVAIL. THE AWARD IN THE ARBITRATION SHALL BE FINAL AND BINDING. THE ARBITRATION SHALL BE
GOVERNED BY THE FEDERAL ARBITRATION ACT, 9 U.S.C. SEC. 1-16, AND THE JUDGMENT UPON THE AWARD RENDERED BY THE ARBITRATORS MAY BE
ENTERED BY ANY COURT HAVING JURISDICTION THEREOF. OPCO AND THE PLACEMENT AGENT AGREE AND CONSENT TO PERSONAL JURISDICTION, SERVICE
OF PROCESS AND VENUE IN ANY FEDERAL OR STATE COURT WITHIN THE STATE AND COUNTY OF NEW YORK IN CONNECTION WITH ANY ACTION BROUGHT
TO ENFORCE AN AWARD IN ARBITRATION.

 

    	 	-32-	 

    	 	 	 

    

 

14.
Miscellaneous. No provision of this Agreement may be changed or terminated except by a writing signed by the party or parties
to be charged therewith. Unless expressly so provided, no party to this Agreement will be liable for the performance of any other
party’s obligations hereunder. Either party hereto may waive compliance by the other with any of the terms, provisions and
conditions set forth herein; provided, however, that any such waiver shall be in writing specifically setting forth those provisions
waived thereby. No such waiver shall be deemed to constitute or imply waiver of any other term, provision or condition of this
Agreement. Neither party may assign its rights or obligations under this Agreement to any other person or entity without the prior
written consent of the other party.

 

15.
Entire Agreement; Severability. This Agreement together with any other agreement referred to herein supersedes all prior
understandings and written or oral agreements between the parties with respect to the Offering and the subject matter hereof.
If any portion of this Agreement shall be held invalid or unenforceable, then so far as is reasonable and possible (i) the remainder
of this Agreement shall be considered valid and enforceable and (ii) effect shall be given to the intent manifested by the portion
held invalid or unenforceable.

 

16.
Counterparts. This Agreement may be executed in multiple counterparts, each of which may be executed by less than all of
the parties and shall be deemed to be an original instrument which shall be enforceable against the parties actually executing
such counterparts and all of which together shall constitute one and the same instrument. The exchange of copies of this Agreement
and of signature pages by facsimile transmission shall constitute effective execution and delivery of this Agreement as to the
parties and may be used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile
shall be deemed to be their original signatures for all purposes.

 

[Signatures
on following page.]

 

    	 	-33-	 

    	 	 	 

    

 

If
the foregoing is in accordance with your understanding of the agreement among Issuer, OPCO and the Placement Agent, kindly sign
and return this Agreement, whereupon it will become a binding agreement among Issuer, OPCO and the Placement Agent in accordance
with its terms.

 

	MOTUS GI MEDICAL TECHNOLOGIES LTD.	 
	 	 	 
	By:	/s/
    Mark Pomeranz	 
	Name:	Mark
    Pomeranz	 
	Title:	Chief
    Executive Officer	 
	 	 	 
	MOTUS GI HOLDINGS, INC.	 
	 	 	 
	By:	/s/
    Todd Van Emburgh	 
	Name:	Todd
    Van Emburgh	 
	Title:	President	 
	 	 	 
	Accepted and agreed to this	 
	1st day of December, 2016:	 
	 	 	 
	AEGIS CAPITAL CORP.	 
	 	 	 
	By:	/s/
    Adam K. Stern	 
	Name:	Adam
    K. Stern	 
	Title:	Head
    of Private Equity Banking	 

 

[Signature
Page to Placement Agency Agreement]

 

    	 	 	 

    	 	 	 

    

 

SCHEDULE
A

 

Engagement
Letter dated November 23, 2015 and subsequent letter dated November 15, 2016 between Motus GI Medical Technologies Ltd. and Leerink
Partners LLC (“Leerink”) pursuant to which Leerink was engaged as the exclusive financial advisor in connection with
a possible Financing, Sale Transaction or Strategic Alliance.

 

    	 	 	 

    	 	 	 

    

 

SCHEDULE
B-1

 

Cormorant
Asset Management

Perceptive
Life Sciences

Ghost
Tree Capital

Great
Point Partners

HIG
Capital

New
Enterprise Associates

Cowen
Group

JW
Partners

 

    	 	 	 

    	 	 	 

    

 

SCHEDULE
B-2

 

Ally-Bridge

Apple
Tree Partners

Arboretum
Ventures

Ascension
Health Ventures

Baird
Capital

Canaan
Partners

Domain
Associates

Edmond
de Rothchild

Endeavour
Vision

Essex
Woodlands

F-Prime
Capital

HBM
Healthcare Investments

HealthQuest

HillHouse
Capital

Kofa
Capital

Lightstone
Capital

Longitude

Lumira
Capital

Majalin
Capital

MVM
Life Science Partners

Norwest
Venture Partners

Novartis
Venture Funds

Novo
Ventures

Orbimed
Advisors

Pappas
Ventures

Pentax
Medical

RA
Capital Management

Redmile
Group

Relativity

Sailing
Capital

Sectoral
Asset Mgmt

Signet
Healthcare Partners

Summation
Capital (Cedars)

WuXi
Ventures

Boston
Scientific

Hoya
and Affiliates

Medtronic

Nestle
Ventures

OlympusSUBSCRIPTION
AGREEMENT

 

Motus
GI Holdings, Inc.

Motus
GI Medical Technology Ltd.

150
Union Square Drive

New
Hope, PA 18938

 

Ladies
and Gentlemen:

 

1.
Subscription. The undersigned (the “Purchaser”), intending to be legally bound, hereby irrevocably agrees to
purchase from Motus GI Holdings, Inc., a Delaware corporation (the “Company”), the number of units (the “Units”)
set forth on the signature page hereof at a purchase price of $5.00 per Unit. Each Unit consists of (i) three-quarter (3/4) share
of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and (ii) one-quarter (1/4)
share of the Company’s Series A Convertible Preferred Stock, par value $0.0001 per share (the “Series A Stock”),
with a minimum investment amount of $250,000, provided a lower subscription amount may be accepted at the discretion of the Company
and the Placement Agent (as defined below). The Units are being sold in the Offering (as defined below), the initial closing of
which will close contemporaneously with the share exchange transaction whereby the stockholders of Motus GI Medical Technology
Ltd. (“Motus”) will receive shares of the Company’s common stock in consideration for shares and/or warrants
of Motus held by them at the effective time of the Share Exchange Transaction as contemplated by the Share Exchange Agreement,
as more fully described in the Memorandum (as defined below). This Subscription Agreement (this “Subscription Agreement”)
is one in a series of similar subscription agreements (collectively, the “Subscription Agreements”) entered into pursuant
to the Offering.

 

2.
The Offering. This subscription is submitted to you in accordance with and subject to the terms and conditions described
in this Subscription Agreement and the Confidential Private Placement Memorandum of the Company dated December 1, 2016, as amended
or supplemented from time to time, including all attachments, schedules and exhibits thereto (the “Memorandum”), relating
to the offering (the “Offering”) by the Company of a minimum of 4,000,000 Units ($20,000,000) (“Minimum Offering
Amount”), and up to a maximum of 5,000,000 Units ($25,000,000) (“Maximum Offering Amount”). In the event the
Maximum Offering Amount is sold, the Placement Agent (as defined below) and the Company shall have the right to sell up to an
additional 1,000,000 Units ($5,000,000) to cover over-allotments. Aegis Capital Corp. has been engaged as exclusive placement
agent in connection with the Offering (“Aegis” or the “Placement Agent”). The terms of the Offering are
more completely described in the Memorandum and such terms are incorporated herein in their entirety.

 

3.
Deliveries and Payment; Escrow of Funds. Simultaneously with the execution hereof, the Purchaser shall: (a) deliver to
Aegis, in accordance with the Subscription Instructions attached hereto, (i) one (1) completed and executed omnibus signature
page to this Subscription Agreement and the Registration Rights Agreement (page 14), (ii) a completed Accredited Investor Certification
(pages 15-16), (iii) a completed Investor Profile (page 17), (iv) one (1) completed and executed Tax Certification for U.S. Persons
or Non-U.S. Persons, as applicable (beginning on page 19) and (v) one (1) completed and executed Selling Stockholder’s Questionnaire;
and (b) make a wire transfer payment to, “Signature Bank, Escrow Agent for Motus GI Holdings, Inc.” in the full amount
of the purchase price of the Units being subscribed for in the Offering. Wire transfer instructions are set forth on page 12 hereof
under the heading “To subscribe for Units in the private offering of Motus GI Holdings, Inc.” Such funds will be held
for the Purchaser’s benefit in a non-interest-bearing escrow account (the “Escrow Account”) until the earliest
to occur of (a) a closing of the sale of the Minimum Offering Amount or more (the “First Closing”), (b) the rejection
of such subscription, or (c) the termination of the Offering by the Company, Motus or the Placement Agent. The Company, Motus
and the Placement Agent may continue to offer and sell the Units and conduct additional closings for the sale of additional Units
after the First Closing and until the termination of the Offering.

 

    	1

    	 

    

 

4.
Acceptance of Subscription. The Purchaser understands and agrees that the Company and Motus, in their sole discretion,
reserve the right to accept or reject this or any other subscription for Units, in whole or in part, notwithstanding prior receipt
by the Purchaser of notice of acceptance of this subscription. In furtherance of the foregoing, the Company and Motus shall have
the right to require potential subscribers to supply additional information and execute additional documents in a satisfactory
manner, which determination shall be at the sole discretion of the Company and Motus, prior to the acceptance of this Subscription
Agreement. The Company shall have no obligation hereunder until the Company shall execute and deliver to the Purchaser an executed
copy of this Subscription Agreement. If this subscription is rejected in whole, the Offering of Units is terminated or the Minimum
Offering Amount is not raised, all funds received from the Purchaser will be returned without interest or offset, and this Subscription
Agreement shall thereafter be of no further force or effect. If this subscription is rejected in part, the funds for the rejected
portion of this subscription will be returned without interest or offset, and this Subscription Agreement will continue in full
force and effect to the extent this subscription was accepted.

 

5.
Representations and Warranties.

 

The
Purchaser hereby acknowledges, represents, warrants, and agrees as follows:

 

(a)
None of the shares of Common Stock, Series A Stock or shares of Common Stock underlying the Series A Stock (the “Underlying
Common Stock”) offered pursuant to the Memorandum are registered under the Securities Act of 1933, as amended (the “Securities
Act”), or any state securities laws. The Purchaser understands that the offering and sale of the Units is intended to be
exempt from registration under the Securities Act, by virtue of Section 4(a)(2) thereof and the provisions of Regulation D (“Regulation
D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) thereunder, based, in
part, upon the representations, warranties and agreements of the Purchaser contained in this Subscription Agreement;

 

(b)
Prior to the execution of this Subscription Agreement, the Purchaser and the Purchaser’s attorney, accountant, purchaser
representative and/or tax adviser, if any (collectively, the “Advisers”), have received the Memorandum and all other
documents requested by the Purchaser, have carefully reviewed them and understand the information contained therein;

 

    	2

    	 

    

 

(c)
Neither the SEC nor any state securities commission or other regulatory authority has approved the Units, the Common Stock, the
Underlying Common Stock or the Series A Stock, or passed upon or endorsed the merits of the Offering or confirmed the accuracy
or determined the adequacy of the Memorandum. The Memorandum has not been reviewed by any federal, state or other regulatory authority;

 

(d)
All documents, records, and books pertaining to the investment in the Units (including, without limitation, the Memorandum) have
been made available for inspection by such Purchaser and its Advisers, if any;

 

(e)
The Purchaser and its Advisers, if any, have had a reasonable opportunity to ask questions of and receive answers from a person
or persons acting on behalf of the Company concerning the offering of the Units and the business, financial condition and results
of operations of the Company and Motus, and all such questions have been answered to the full satisfaction of the Purchaser and
its Advisers, if any;

 

(f)
In evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representation or information
(oral or written) other than as stated in the Memorandum.

 

(g)
The Purchaser is unaware of, is in no way relying on, and did not become aware of the Offering of the Units through or as a result
of, any form of general solicitation or general advertising including, without limitation, any article, notice, advertisement
or other communication published in any newspaper, magazine or similar media or broadcast over television, radio or the Internet
(including, without limitation, internet “blogs,” bulletin boards, discussion groups and social networking sites)
in connection with the Offering and sale of the Units and is not subscribing for the Units and did not become aware of the Offering
of the Units through or as a result of any seminar or meeting to which the Purchaser was invited by, or any solicitation of a
subscription by, a person not previously known to the Purchaser in connection with investments in securities generally;

 

(h)
The Purchaser has taken no action that would give rise to any claim by any person for brokerage commissions, finders’ fees
or the like relating to this Subscription Agreement or the transactions contemplated hereby (other than commissions to be paid
by the Company to the Placement Agent or as otherwise described in the Memorandum);

 

(i)
The Purchaser, together with its Advisers, if any, has such knowledge and experience in financial, tax, and business matters,
and, in particular, investments in securities, so as to enable it to utilize the information made available to it in connection
with the Offering to evaluate the merits and risks of an investment in the Units and the Company and to make an informed investment
decision with respect thereto;

 

(j)
The Purchaser is not relying on the Company, Motus, the Placement Agent or any of their respective employees or agents with respect
to the legal, tax, economic and related considerations of an investment in the Units, and the Purchaser has relied on the advice
of, or has consulted with, only its own Advisers;

 

    	3

    	 

    

 

(k)
The Purchaser is acquiring the Units solely for such Purchaser’s own account for investment purposes only and not with a
view to or intent of resale or distribution thereof, in whole or in part. The Purchaser has no agreement or arrangement, formal
or informal, with any person to sell or transfer all or any part of the Units, the shares of Common Stock, the Underlying Common
Stock or the Series A Stock, and the Purchaser has no plans to enter into any such agreement or arrangement.

 

(l)
The Purchaser must bear the substantial economic risks of the investment in the Units indefinitely because none of the securities
included in the Units may be sold, hypothecated or otherwise disposed of unless subsequently registered under the Securities Act
and applicable state securities laws or an exemption from such registration is available. Legends shall be placed on the securities
included in the Units to the effect that they have not been registered under the Securities Act or applicable state securities
laws and appropriate notations thereof will be made in the Company’s stock books. Stop transfer instructions will be placed
with the transfer agent of the Units. The Company has agreed that purchasers of the Units will have, with respect to the shares
of Common Stock and the Underlying Common Stock, the registration rights described in the Registration Rights Agreement. Notwithstanding
such registration rights, there can be no assurance that there will be any market for resale of the Units, the Common Stock, the
Underlying Common Stock or the Series A Stock, nor can there be any assurance that such securities will be freely transferable
at any time in the foreseeable future.

 

(m)
The Purchaser has adequate means of providing for such Purchaser’s current financial needs and foreseeable contingencies
and has no need for liquidity from its investment in the Units for an indefinite period of time;

 

(n)
The Purchaser is aware that an investment in the Units is high risk, involving a number of very significant risks and has carefully
read and considered the matters set forth under the caption “Risk Factors” in the Memorandum, and, in particular,
acknowledges that Motus has a limited operating history, significant operating losses since inception, no revenues from operations
to date, limited assets and is engaged in a highly competitive business;

 

(o)
The Purchaser meets the requirements of at least one of the suitability standards for an “accredited investor” as
that term is defined in Regulation D and as set forth on the Accredited Investor Certification contained herein;

 

(p)
The Purchaser (i) if a natural person, represents that the Purchaser has reached the age of 21 and has full power and authority
to execute and deliver this Subscription Agreement and all other related agreements or certificates and to carry out the provisions
hereof and thereof; (ii) if a corporation, partnership, or limited liability company or partnership, or association, joint stock
company, trust, unincorporated organization or other entity, represents that such entity was not formed for the specific purpose
of acquiring the Units, such entity is duly organized, validly existing and in good standing under the laws of the state of its
organization, the consummation of the transactions contemplated hereby is authorized by, and will not result in a violation of
state law or its charter or other organizational documents, such entity has full power and authority to execute and deliver this
Subscription Agreement and all other related agreements or certificates and to carry out the provisions hereof and thereof and
to purchase and hold the securities constituting the Units, the execution and delivery of this Subscription Agreement has been
duly authorized by all necessary action, this Subscription Agreement has been duly executed and delivered on behalf of such entity
and is a legal, valid and binding obligation of such entity; or (iii) if executing this Subscription Agreement in a representative
or fiduciary capacity, represents that it has full power and authority to execute and deliver this Subscription Agreement in such
capacity and on behalf of the subscribing individual, ward, partnership, trust, estate, corporation, or limited liability company
or partnership, or other entity for whom the Purchaser is executing this Subscription Agreement, and such individual, partnership,
ward, trust, estate, corporation, or limited liability company or partnership, or other entity has full right and power to perform
pursuant to this Subscription Agreement and make an investment in the Company, and represents that this Subscription Agreement
constitutes a legal, valid and binding obligation of such entity. The execution and delivery of this Subscription Agreement will
not violate or be in conflict with any order, judgment, injunction, agreement or controlling document to which the Purchaser is
a party or by which it is bound;

 

    	4

    	 

    

 

(q)
The Purchaser and the Advisers, if any, have had the opportunity to obtain any additional information, to the extent the Company
and/or Motus have such information in its possession or could acquire it without unreasonable effort or expense, necessary to
verify the accuracy of the information contained in the Memorandum and all documents received or reviewed in connection with the
purchase of the Units and have had the opportunity to have representatives of the Company and Motus provide them with such additional
information regarding the terms and conditions of this particular investment and the financial condition, results of operations,
business of the Company and Motus deemed relevant by the Purchaser or the Advisers, if any, and all such requested information,
to the extent the Company or Motus had such information in their possession or could acquire it without unreasonable effort or
expense, has been provided to the full satisfaction of the Purchaser and the Advisers, if any;

 

(r)
Any information which the Purchaser has heretofore furnished or is furnishing herewith to the Company, Motus or the Placement
Agent is complete and accurate and may be relied upon by the Company, Motus and the Placement Agent in determining the availability
of an exemption from registration under federal and state securities laws in connection with the offering of securities as described
in the Memorandum. The Purchaser further represents and warrants that it will notify and supply corrective information to the
Company, Motus and the Placement Agent immediately upon the occurrence of any change therein occurring prior to the Company’s
issuance of the securities contained in the Units;

 

(s)
The Purchaser has significant prior investment experience, including investment in non-listed and non-registered securities. The
Purchaser is knowledgeable about investment considerations in development-stage companies with limited operating histories. The
Purchaser has a sufficient net worth to sustain a loss of its entire investment in the Company in the event such a loss should
occur. The Purchaser’s overall commitment to investments which are not readily marketable is not excessive in view of the
Purchaser’s net worth and financial circumstances and the purchase of the Units will not cause such commitment to become
excessive. The investment is a suitable one for the Purchaser;

 

(t)
The Purchaser is satisfied that the Purchaser has received adequate information with respect to all matters which it or the Advisers,
if any, consider material to its decision to make this investment;

 

    	5

    	 

    

 

(u)
The Purchaser acknowledges that any estimates or forward-looking statements or projections included in the Memorandum were prepared
by the Company and Motus in good faith but that the attainment of any such projections, estimates or forward-looking statements
cannot be guaranteed by the Company or Motus and should not be relied upon;

 

(v)
No oral or written representations have been made, or oral or written information furnished, to the Purchaser or the Advisers,
if any, in connection with the Offering which are in any way inconsistent with the information contained in the Memorandum;

 

(w)
Within five (5) days after receipt of a request from the Company, Motus or any Placement Agent, the Purchaser will provide such
information and deliver such documents as may reasonably be necessary to comply with any and all laws and ordinances to which
the Company, Motus or the Placement Agent is subject;

 

(x)
The Purchaser’s substantive relationship with either Placement Agent or subagent through which the Purchaser is subscribing
for Units predates such Placement Agent’s or such subagent’s contact with the Purchaser regarding an investment in
the Units;

 

(y)
THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS
AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS. THE SECURITIES
ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SAID
ACT AND SUCH LAWS PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE SECURITIES HAVE NOT BEEN RECOMMENDED, APPROVED OR DISAPPROVED
BY THE SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF
THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY OR ADEQUACY OF THE MEMORANDUM OR
THIS SUBSCRIPTION AGREEMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL;

 

(z)
In making an investment decision investors must rely on their own examination of the Company, Motus and the terms of the Offering,
including the merits and risks involved. The Purchaser should be aware that it will be required to bear the financial risks of
this investment for an indefinite period of time;

 

(aa)
(For ERISA plans only) The fiduciary of the ERISA plan (the “Plan”) represents that such fiduciary has been
informed of and understands the Company’s investment objectives, policies and strategies, and that the decision to invest
“plan assets” (as such term is defined in ERISA) in the Company is consistent with the provisions of ERISA that require
diversification of plan assets and impose other fiduciary responsibilities. The Purchaser fiduciary or Plan (a) is responsible
for the decision to invest in the Company; (b) is independent of the Company or any of its affiliates; (c) is qualified to make
such investment decision; and (d) in making such decision, the Purchaser fiduciary or Plan has not relied primarily on any advice
or recommendation of the Company or any of its affiliates;

 

    	6

    	 

    

 

(bb)
The Purchaser should check the Office of Foreign Assets Control (“OFAC”) website at <http://www.treas.gov/ofac>
before making the following representations. The Purchaser represents that the amounts invested by it in the Company in the
Offering were not and are not directly or indirectly derived from activities that contravene federal, state or international laws
and regulations, including anti-money laundering laws and regulations. Federal regulations and Executive Orders administered by
OFAC prohibit, among other things, the engagement in transactions with, and the provision of services to, certain foreign countries,
territories, entities and individuals. The lists of OFAC prohibited countries, territories, persons and entities can be found
on the OFAC website at <http://www.treas.gov/ofac>. In addition, the programs administered by OFAC (the “OFAC Programs”)
prohibit dealing with individuals[1] or entities in certain countries regardless of whether such individuals or entities
appear on the OFAC lists;

 

(cc)
To the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a country, territory, individual or entity
named on an OFAC list, or a person or entity prohibited under the OFAC Programs. Please be advised that the Company may not accept
any amounts from a prospective investor if such prospective investor cannot make the representation set forth in the preceding
paragraph. The Purchaser agrees to promptly notify the Company, Motus and the Placement Agent should the Purchaser become aware
of any change in the information set forth in these representations. The Purchaser understands and acknowledges that, by law,
the Company may be obligated to “freeze the account” of the Purchaser, either by prohibiting additional subscriptions
from the Purchaser, declining any redemption requests and/or segregating the assets in the account in compliance with governmental
regulations, and the Placement Agent may also be required to report such action and to disclose the Purchaser’s identity
to OFAC. The Purchaser further acknowledges that the Company may, by written notice to the Purchaser, suspend the redemption rights,
if any, of the Purchaser if the Company reasonably deems it necessary to do so to comply with anti-money laundering regulations
applicable to the Company and the Placement Agent or any of the Company’s other service providers. These individuals include
specially designated nationals, specially designated narcotics traffickers and other parties subject to OFAC sanctions and embargo
programs;

 

(dd)
To the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a senior foreign political figure,[2]
or any immediate family[3] member or close associate[4] of a senior foreign political figure, as such
terms are defined in the footnotes below; and

 

 

1
These individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject
to OFAC sanctions and embargo programs.

 

2
A “senior foreign political figure” is defined as a senior official in the executive, legislative, administrative,
military or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign political
party, or a senior executive of a foreign government-owned corporation. In addition, a “senior foreign political figure”
includes any corporation, business or other entity that has been formed by, or for the benefit of, a senior foreign political
figure.

 

    	7

    	 

    

 

(ee)
If the Purchaser is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Purchaser receives
deposits from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Purchaser represents
and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a country
in which the Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related
to its banking activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank
to conduct banking activities; and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that does
not have a physical presence in any country and that is not a regulated affiliate.

 

6.
Lockup. (A) The Purchaser hereby acknowledges and agrees to the contractual restriction on transfer that will be applicable
to the shares of Common Stock, the Underlying Common Stock and the Series A Stock as set forth in Section 3(f) of the Registration
Rights Agreement, whether or not it becomes a party to the Registration Rights Agreement.

 

(B)
Notwithstanding paragraph (A), if the Purchaser is an affiliate of the Company, Holdings or the Placement Agent (together an “Affiliate
Purchaser”), such Affiliate Purchaser acknowledges and agrees that he will not become a party to the Registration Rights
Agreement, and that he will be required to execute a Lock Up Agreement on terms to be provided to him.

 

7.
Indemnification. The Purchaser agrees to indemnify and hold harmless the Company, Motus, the Placement Agent (including
its selected dealers, if any), and their respective officers, directors, employees, agents, control persons and affiliates from
and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but not limited to, any
and all expenses incurred in investigating, preparing or defending against any litigation commenced or threatened) based upon
or arising out of any actual or alleged false acknowledgment, representation or warranty, or misrepresentation or omission to
state a material fact, or breach by the Purchaser of any covenant or agreement made by the Purchaser herein or in any other document
delivered in connection with this Subscription Agreement.

 

8.
Irrevocability; Binding Effect. The Purchaser hereby acknowledges and agrees that the subscription hereunder is irrevocable
by the Purchaser, except as required by applicable law, and that this Subscription Agreement shall survive the death or disability
of the Purchaser and shall be binding upon and inure to the benefit of the parties and their heirs, executors, administrators,
successors, legal representatives, and permitted assigns. If the Purchaser is more than one person, the obligations of the Purchaser
hereunder shall be joint and several and the agreements, representations, warranties, and acknowledgments herein shall be deemed
to be made by and be binding upon each such person and such person’s heirs, executors, administrators, successors, legal
representatives, and permitted assigns.

 

 

3
“Immediate family” of a senior foreign political figure typically includes the figure’s parents, siblings,
spouse, children and in-laws.

 

4
A “close associate” of a senior foreign political figure is a person who is widely and publicly known to maintain
an unusually close relationship with the senior foreign political figure, and includes a person who is in a position to conduct
substantial domestic and international financial transactions on behalf of the senior foreign political figure.

 

    	8

    	 

    

 

9.
Modification. This Subscription Agreement shall not be modified or waived except by an instrument in writing signed by
the party against whom any such modification or waiver is sought.

 

10.
Immaterial Modifications to the Registration Rights Agreement. The Company may, at any time prior to the First Closing,
modify the Registration Rights Agreement if necessary to clarify any provision therein, without first providing notice or obtaining
prior consent of the Subscriber, if, and only if, such modification is not material in any respect.

 

11.
Notices. Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be
deemed effectively given: (a) upon personal delivery to the party notified, (b) when sent by confirmed email or facsimile if sent
during normal business hours of the recipient, or if not confirmed, then on the next business day, (c) five days after having
been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally
recognized overnight courier, specifying next day delivery, with written verification of receipt. The Company and the Purchaser
hereby consent to the delivery of communications and notices to such parties at their respective address, email or facsimile number
set forth on the signature page hereto, or to such other address as such party shall have furnished in writing in accordance with
the provisions of this Section 11.

 

12.
Assignability. This Subscription Agreement and the rights, interests and obligations hereunder are not transferable or
assignable by the Purchaser and the transfer or assignment of the shares of Common Stock or the Series A Stock shall be made only
in accordance with all applicable laws.

 

13.
Applicable Law. This Subscription Agreement shall be governed by and construed in accordance with the laws of the State
of New York applicable to contracts to be wholly-performed within said State.

 

14.
Arbitration. The parties agree to submit all controversies to arbitration in accordance with the provisions set forth below
and understand that:

 

(a)
Arbitration is final and binding on the parties.

 

(b)
The parties are waiving their right to seek remedies in court, including the right to a jury trial.

 

(c)
Pre-arbitration discovery is generally more limited and different from court proceedings.

 

(d)
The arbitrator’s award is not required to include factual findings or legal reasoning and any party’s right to appeal
or to seek modification of rulings by arbitrators is strictly limited.

 

(e)
The panel of arbitrators will typically include a minority of arbitrators who were or are affiliated with the securities industry.

 

(f)
All controversies which may arise between the parties concerning this Subscription Agreement shall be determined by arbitration
pursuant to the rules then pertaining to the Financial Industry Regulatory Authority (“FINRA”) in New York City, New
York. Judgment on any award of any such arbitration may be entered in the Supreme Court of the State of New York or in any other
court having jurisdiction of the person or persons against whom such award is rendered. Any notice of such arbitration
or for the confirmation of any award in any arbitration shall be sufficient if given in accordance with the provisions of this
Agreement. The parties agree that the determination of the arbitrators shall be binding and conclusive upon them.

 

    	9

    	 

    

 

15.
Blue Sky Qualification. The purchase of Units under this Subscription Agreement is expressly conditioned upon the exemption
from qualification of the offer and sale of the Units from applicable federal and state securities laws. The Company shall not
be required to qualify this transaction under the securities laws of any jurisdiction and, should qualification be necessary,
the Company shall be released from any and all obligations to maintain its offer, and may rescind any sale contracted, in the
jurisdiction.

 

16.
Use of Pronouns. All pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine,
neuter, singular or plural as the identity of the person or persons referred to may require.

 

17.
Confidentiality. The Purchaser acknowledges and agrees that any information or data the Purchaser has acquired from or
about the Company or Motus, not otherwise properly in the public domain, was received in confidence. The Purchaser agrees not
to divulge, communicate or disclose, except as may be required by law or for the performance of this Agreement, or use to the
detriment of the Company or Motus or for the benefit of any other person or persons, or misuse in any way, any confidential information
of the Company or Motus, including any scientific, technical, trade or business secrets of the Company or Motus and any scientific,
technical, trade or business materials that are treated by the Company or Motus as confidential or proprietary, including, but
not limited to, ideas, discoveries, inventions, developments and improvements belonging to the Company or Motus and confidential
information obtained by or given to the Company or Motus about or belonging to third parties.

 

18.
Miscellaneous.

 

(a)
This Subscription Agreement, together with the Registration Rights Agreement, constitute the entire agreement between the Purchaser
and the Company with respect to the subject matter hereof and supersede all prior oral or written agreements and understandings,
if any, relating to the subject matter hereof. The terms and provisions of this Subscription Agreement may be waived, or consent
for the departure therefrom granted, only by a written document executed by the party entitled to the benefits of such terms or
provisions.

 

(b)
The representations and warranties of the Company and the Purchaser made in this Subscription Agreement shall survive the execution
and delivery hereof and delivery of the shares of Common Stock and Series A Stock contained in the Units.

 

(c)
Each of the parties hereto shall pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or
others engaged by such party) in connection with this Subscription Agreement and the transactions contemplated hereby whether
or not the transactions contemplated hereby are consummated.

 

    	10

    	 

    

 

(d)
This Subscription Agreement may be executed in one or more counterparts each of which shall be deemed an original, but all of
which shall together constitute one and the same instrument.

 

(e)
Each provision of this Subscription Agreement shall be considered separable and, if for any reason any provision or provisions
hereof are determined to be invalid or contrary to applicable law, such invalidity or illegality shall not impair the operation
of or affect the remaining portions of this Subscription Agreement.

 

(f)
Paragraph titles are for descriptive purposes only and shall not control or alter the meaning of this Subscription Agreement as
set forth in the text.

 

(g)
The Purchaser understands and acknowledges that there may be multiple closings for this Offering.

 

19.
Omnibus Signature Page. This Subscription Agreement is intended to be read and construed in conjunction with the Registration
Rights Agreement pertaining to the issuance by the Company of the shares of Common Stock and Series A Stock to subscribers pursuant
to the Memorandum. Accordingly, pursuant to the terms and conditions of this Subscription Agreement and such related agreements
it is hereby agreed that the execution by the Purchaser of this Subscription Agreement, in the place set forth herein, shall constitute
agreement to be bound by the terms and conditions hereof and the terms and conditions of the Registration Rights Agreement, with
the same effect as if each of such separate but related agreement were separately signed.

 

20.
Book Entry Registration of the Shares. The Company will issue the Common Stock and Series A Stock (together, the “Shares”)
by registering the Shares in book entry form with the Company’s transfer agent in Investor’s name and the applicable
restrictions will be noted in the records of the Company’s transfer agent and in the book entry system, except for investments
made via custodian accounts such as Pensions and IRA’s in which case physical certificates evidencing the Shares will be
issued.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	11

    	 

    

 

PRIVATE
PLACEMENT OFFERING OF

MOTUS
GI HOLDINGS, INC.

 

SUBSCRIPTION
INSTRUCTIONS

 

To
subscribe for Units in the private offering of Motus GI Holdings, Inc.:

 

	1.	Date
    and Fill in the dollar amount of Units being purchased and Complete and Sign the Omnibus Signature Page to the
    Subscription Agreement and the Registration Rights Agreement (page 14).
	 	 
	2.	Initial
    the Accredited Investor Certification page attached to the Subscription Agreement (page 15-16).
	 	 
	3.	Complete
    and return the Investor Profile (page 17).
	 	 
	4.	Complete
    and Sign the Tax Certification for U.S. Persons or Non-U.S. Persons, as applicable (beginning on page 19).
	 	 
	5.	Fax
    or e-mail all forms (except the Selling Stockholder Questionnaire noted in Item 7 below) to Tierney S. Picardal at 347-772-3121/Tierney@sternaegis.com
    and then send all signed original documents to:
	 	 
	6.	Please
    wire funds directly to the escrow account pursuant to the following instructions (unless other arrangements have been made);
    checks cannot be accepted:

 

Bank
Name: Signature Bank

Bank
Address: 950 Third Avenue, 9th Floor, New York, NY 10022, Attn: PCG# 311

ABA
Number:

Swift
Code (for US Dollars wired outside the USA): SIGNUS33

A/C
Name: Signature Bank, as Agent for Motus GI Holdings, Inc.

A/C
Number:

FBO: Investor Name____________ 

SSN/TIN_____________________ 

Address______________________ 

 

	7.	Complete
    and return the entire Stockholders Questionnaire (pages A-1 through A-20) by fax or email to Robert Bee, Esq. at: (973)-597-2400/RBee@lowenstein.com
    and then send all signed original documents to:

 

Lowenstein
Sandler LLP

65
Livingston Avenue

Roseland,
NJ 07068

Attn:
Robert Bee, Esq

 

    	12

    	 

    

 

ANTI
MONEY LAUNDERING REQUIREMENTS

 

	The
    USA PATRIOT Act	 	What
    is money laundering?	 	How
    big is the problem and why is it important?
	 	 	 	 	 
	The
                                         USA PATRIOT Act is designed to detect, deter, and punish terrorists in the United States
                                         and abroad. The Act imposes new anti-money laundering requirements on brokerage firms
                                         and financial institutions. Since April 24, 2002 all brokerage firms have been required
                                         to have new, comprehensive anti-money laundering programs.

         

        To
        help you understand these efforts, we want to provide you with some information about money laundering and the Placement
        Agent’s efforts to implement the USA PATRIOT Act.
	 	Money
    laundering is the process of disguising illegally obtained money so that the funds appear to come from legitimate sources
    or activities. Money laundering occurs in connection with a wide variety of crimes, including illegal arms sales, drug trafficking,
    robbery, fraud, racketeering, and terrorism.	 	The
    use of the U.S. financial system by criminals to facilitate terrorism or other crimes could well taint our financial markets.
    According to the U.S. State Department, one recent estimate puts the amount of worldwide money laundering activity at $1 trillion
    a year.

 

	What
    each Placement Agent is required to do to help eliminate money laundering?
	 
	 

        Under
        new rules required by the USA PATRIOT Act, the Placement Agent’s anti-money laundering program must designate a
        special compliance officer, set up employee training, conduct independent audits, and establish policies and procedures
        to detect and report suspicious transaction and ensure compliance with the new laws.
	 	 

        As
        part of the Placement Agent’s required program, it may ask you to provide various identification documents or other
        information. Until you provide the information or documents that the Placement Agent needs, it may not be able to effect
        any transactions for you.

 

    	13

    	 

    

 

Motus
GI Holdings, Inc.

OMNIBUS
SIGNATURE PAGE TO THE

SUBSCRIPTION
AGREEMENT

AND
REGISTRATION RIGHTS AGREEMENT

 

Subscriber
hereby elects to subscribe under the Subscription Agreement for a total of $_________ of Units at a price of $5.00 per Unit (NOTE:
to be completed by subscriber) and, by execution and delivery hereof (return one (1) original), Subscriber hereby executes the
Subscription Agreement and agrees to be bound by the terms and conditions of the Subscription Agreement and the Registration Rights
Agreement.

 

If
the Purchaser is an INDIVIDUAL, and if purchased as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY:

 

	 	 	 
	Print
    Name(s)	 	Social
    Security Number(s)
	 	 	 
	 	 	 
	Signature(s)
    of Subscriber(s)	 	Signature
	 	 	 
	 	 	 
	Date	 	Address

 

If
the Purchaser is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY, IRA or TRUST:

 

	 	 	 
	Name
    of Entity	 	Federal
    Taxpayer
	 	 	Identification
    Number
	 	 	 
	By:	 	 	
	Name:	 	 	State
    of Organization
	Title:	 	 	 
	 	 	 
	 	 	 
	Date	 	Address
	 	 	 
	 	 	 
	Fax
    Number	 	Email
    Address

 

	Motus
    GI Holdings, Inc.	 	AEGIS
    CAPITAL CORP.
	 	 	 	 	 
	By:	 	 	By:	 
	 	Authorized
    Officer	 	 	Authorized
    Officer
	 	 	 	 	 
	Motus
    GI Medical Technology Ltd. 	 	 	 
	 	 	 	 	 
	By:
    	 	 	 	 
	 	Authorized
    Officer	 	 	 

 

    	14

    	 

    

 

Motus
GI Holdings, Inc.

ACCREDITED
INVESTOR CERTIFICATION

 

For
Individual Investors Only

(all
Individual Investors must INITIAL where appropriate):

 

	Initial
    _______ 	I
    have an individual net worth, or joint net worth with my spouse, as of the date hereof in excess of $1 million. For purposes
    of calculating net worth under this category, (i) the undersigned’s primary residence shall not be included as an asset,
    (ii) indebtedness that is secured by the undersigned’s primary residence, up to the estimated fair market value of the
    primary residence at the time of the sale of securities, shall not be included as a liability, (iii) to the extent that the
    indebtedness that is secured by the primary residence is in excess of the fair market value of the primary residence, the
    excess amount shall be included as a liability, and (iv) if the amount of outstanding indebtedness that is secured by the
    primary residence exceeds the amount outstanding 60 days prior to the execution of this Subscription Agreement, other than
    as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability.
	 	 
	Initial
    _______	I
    have had an annual gross income for the past two years of at least $200,000 (or $300,000 jointly with my spouse) and expect
    my income (or joint income, as appropriate) to reach the same level in the current year.
	 	 
	Initial
    _______	I
    am a director or executive officer of Motus GI Holdings, Inc.

 

For
Non-Individual Investors

(all
Non-Individual Investors must INITIAL where appropriate):

 

	Initial
    _______	The
    investor certifies that it is a partnership, corporation, limited liability company or business trust that is 100% owned by
    persons who meet at least one of the criteria for Individual Investors set forth above. 
	 	 
	Initial
    _______	The
    investor certifies that it is a partnership, corporation, limited liability company or any organization described in Section
    501(c)(3) of the Internal Revenue Code, Massachusetts or similar business trust that has total assets of at least $5 million
    and was not formed for the purpose of investing the Company.
	 	 
	Initial
    _______	The
    investor certifies that it is an employee benefit plan within the meaning of the Employee Retirement Income Security Act of
    1974, whose investment decision is made by a plan fiduciary (as defined in ERISA §3(21)) that is a bank, savings and
    loan association, insurance company or registered investment adviser.
	 	 
	Initial
    _______	The
    investor certifies that it is an employee benefit plan whose total assets exceed $5,000,000 as of the date of this Agreement.

 

    	15

    	 

    

 

	Initial
    _______	The
    undersigned certifies that it is a self-directed employee benefit plan whose investment decisions are made solely by persons
    who meet either of the criteria for Individual Investors.
	 	 
	Initial
    _______	The
    investor certifies that it is a U.S. bank, U.S. savings and loan association or other similar U.S. institution acting in its
    individual or fiduciary capacity.
	 	 
	Initial
    _______	The
    undersigned certifies that it is a broker-dealer registered pursuant to §15 of the Securities Exchange Act of 1934.
	 	 
	Initial
    _______	The
    investor certifies that it is an organization described in §501(c)(3) of the Internal Revenue Code with total assets
    exceeding $5,000,000 and not formed for the specific purpose of investing in the Company.
	 	 
	Initial
    _______	The
    investor certifies that it is a trust with total assets of at least $5,000,000, not formed for the specific purpose of investing
    in the Company, and whose purchase is directed by a person with such knowledge and experience in financial and business matters
    that he is capable of evaluating the merits and risks of the prospective investment.
	 	 
	Initial
    _______	The
    investor certifies that it is a plan established and maintained by a state or its political subdivisions, or any agency or
    instrumentality thereof, for the benefit of its employees, and which has total assets in excess of $5,000,000.
	 	 
	Initial
    _______	The
    investor certifies that it is an insurance company as defined in §2(13) of the Securities Act, or a registered investment
    company.
	 	 
	Initial
    _______	An
    investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section
    2(a)(48) of that Act.
	 	 
	Initial
    _______	A
    Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small
    Business Investment Act of 1958.
	 	 
	Initial
    _______	A
    private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940.

 

    	16

    	 

    

 

Motus
GI Holdings, Inc.

Investor
Profile (Must be completed by Investor)

 

Section
A - Personal Investor Information

 

For
All Purchasers

 

Certificate
Title: ______________________________________________________________________________

Individual(s)
executing this subscription: __________________________________________________________

Social
Security Number(s) / Entity Federal I.D. Number: ______________________________________________

Date(s)
of Birth: ______________ 

Marital
Status: ______________

Years
Investment Experience: ______________ 

Aegis
Capital Account Executive or Outside Broker/Dealer: ______________/ Aegis Rep 3-Digit I.D.______

Aegis
Acct #_________________

Check
if you are a FINRA member or affiliate of a FINRA member firm: ____

Check
Investment Objective(s) (See definitions on following page): ____Preservation of Capital ____Income

____Capital
Appreciation ____Trading Profits ____Speculation

____Other
(please specify)

The
source of funds for this investment is my personal or my entity’s assets _____ Yes _____ No

For
Purchasers as Individual or as Joint Tenants, Tenants in Common, and Community Property 

Annual
Income(s): ___________________ 

Liquid
Net Worth(s): _________________

Net
Worth(s) (excluding value of primary residence): ________________

Select
Tax Bracket(s): ____ 15% or below ____ 25% - 27.5% ____ Over 27.5%

 

For
All Purchasers, by the Primary Contact

 

Home
Street Address: ______________________________________________________________________

Home
City, State & Zip Code: _______________________________________________________________

Home
Phone: ___________________ Home Fax: _________________Home Email: ____________________

 

Employer:
___________________________________

Type
of Business: _____________________________

Employer
Street Address: ___________________________________________________________________

Employer
City, State & Zip Code: ____________________________________________________________

Bus.
Phone: _____________________Bus. Fax: ___________________Bus. Email: ____________________

 

For
All Purchasers

 

If
you are a United States citizen, please list the number and jurisdiction of issuance of any other government-issued
document evidencing residence and bearing a photograph or similar safeguard (such as a driver’s license or passport), and
provide a photocopy of each of the documents you have listed.

 

If
you are NOT a United States citizen, for each jurisdiction of which you are a citizen or in which
you work or reside, please list (i) your passport number and country of issuance or (ii) alien identification card number AND
(iii) number and country of issuance of any other government-issued document evidencing nationality or residence and bearing
a photograph or similar safeguard, and provide a photocopy of each of these documents you have listed. These photocopies must
be certified by a lawyer as to authenticity.

 

Government-Issued
Identification Document Number(s) and Jurisdiction(s):___________________________

 

Please
provide a legible photocopy of your Identification Document(s) along with your subscription

 

Section
B – Securities Delivery Instructions

 

____
Please deliver securities to the Employer Address listed in Section A.

____
Please deliver securities to the Home Address listed in Section A.

____
Please deliver securities to the following address: _____________________________________________

 

Section
C –Wire Transfer Instructions

 

____
I will wire funds from my outside account according to the “Subscription Instructions” Page.

____
I will wire funds from my Aegis Capital Account.

____The
funds for this investment are rolled over, tax deferred from __________ within the allowed 60 day window.

 

	 	 	 
	Investor
    Signature	 	Date
	 	 	 
	 	 	 
	Investor
    Signature	 	Date

 

    	17

    	 

    

 

Investment
Objectives: The typical investment listed with each objective are only some examples of the kinds of investments that have
historically been consistent with the listed objectives. However, neither Motus GI Holdings, Inc., Motus GI Medical Technology
Ltd., nor Aegis Capital Corp. can assure that any investment will achieve your intended objective. You must make your own investment
decisions and determine for yourself if the investments you select are appropriate and consistent with your investment objectives.

 

Neither
Motus GI Holdings, Inc., Motus GI Medical Technology Ltd., nor Aegis Capital Corp. assumes responsibility to you for determining
if the investments you selected are suitable for you.

 

Preservation
of Capital: An investment objective of Preservation of Capital indicates you seek to maintain the principal value of
your investments and are interested in investments that have historically demonstrated a very low degree of risk of loss of principal
value. Some examples of typical investments might include money market funds and high quality, short-term fixed income products.

 

Income:
An investment objective of Income indicates you seek to generate income from investments and are interested in investments
that have historically demonstrated a low degree of risk of loss of principal value. Some examples of typical investments might
include high quality, short and medium-term fixed income products, short-term bond funds and covered call options.

 

Capital
Appreciation: An investment objective of Capital Appreciation indicates you seek to grow the principal value of your
investments over time and are willing to invest in securities that have historically demonstrated a moderate to above average
degree of risk of loss of principal value to pursue this objective. Some examples of typical investments might include common
stocks, lower quality, medium-term fixed income products, equity mutual funds and index funds.

 

Trading
Profits: An investment objective of Trading Profits indicates you seek to take advantage of short-term trading opportunities,
which may involve establishing and liquidating positions quickly. Some examples of typical investments might include short-term
purchases and sales of volatile or low priced common stocks, put or call options, spreads, straddles and/or combinations on equities
or indexes. This is a high-risk strategy.

 

Speculation:
An investment objective of Speculation indicates you seek a significant increase in the principal value of your investments
and are willing to accept a corresponding greater degree of risk by investing in securities that have historically demonstrated
a high degree of risk of loss of principal value to pursue this objective. Some examples of typical investments might include
lower quality, long-term fixed income products, initial public offerings, volatile or low priced common stocks, the purchase or
sale of put or call options, spreads, straddles and/or combinations on equities or indexes, and the use of short-term or day trading
strategies.

 

Other:
Please specify.

 

    	18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]